<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article"><?properties manuscript?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-journal-id">9814863</journal-id><journal-id journal-id-type="pubmed-jr-id">21942</journal-id><journal-id journal-id-type="nlm-ta">J Alzheimers Dis</journal-id><journal-id journal-id-type="iso-abbrev">J Alzheimers Dis</journal-id><journal-title-group><journal-title>Journal of Alzheimer's disease : JAD</journal-title></journal-title-group><issn pub-type="ppub">1387-2877</issn><issn pub-type="epub">1875-8908</issn></journal-meta><article-meta><article-id pub-id-type="pmid">39610293</article-id><article-id pub-id-type="pmc">12261283</article-id><article-id pub-id-type="doi">10.1177/13872877241302350</article-id><article-id pub-id-type="manuscript">NIHMS2086140</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Exposure Duration and Cerebral Amyloidosis in the Olfactory Cortex of World Trade Center Responders: A Positron Emission Tomography and Magnetic Resonance Imaging Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kritikos</surname><given-names>Minos</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Juin-Wan</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Chuan</given-names></name><xref rid="A3" ref-type="aff">c</xref></contrib><contrib contrib-type="author"><name><surname>Gandy</surname><given-names>Sam</given-names></name><xref rid="A4" ref-type="aff">d</xref><xref rid="A5" ref-type="aff">e</xref></contrib><contrib contrib-type="author"><name><surname>Pellecchia</surname><given-names>Alison C.</given-names></name><xref rid="A6" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name><surname>Santiago-Michels</surname><given-names>Stephanie</given-names></name><xref rid="A7" ref-type="aff">g</xref></contrib><contrib contrib-type="author"><name><surname>Carr</surname><given-names>Melissa A.</given-names></name><xref rid="A6" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name><surname>Islam</surname><given-names>Shabab</given-names></name><xref rid="A6" ref-type="aff">f</xref></contrib><contrib contrib-type="author"><name><surname>Yang</surname><given-names>Yuan</given-names></name><xref rid="A1" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><name><surname>Horton</surname><given-names>Megan K.</given-names></name><xref rid="A9" ref-type="aff">i</xref></contrib><contrib contrib-type="author"><name><surname>Lucchini</surname><given-names>Roberto G.</given-names></name><xref rid="A8" ref-type="aff">h</xref><xref rid="A10" ref-type="aff">j</xref></contrib><contrib contrib-type="author"><name><surname>Franceschi</surname><given-names>Ana M.</given-names></name><xref rid="A11" ref-type="aff">k</xref></contrib><contrib contrib-type="author"><name><surname>Bangiyev</surname><given-names>Lev</given-names></name><xref rid="A12" ref-type="aff">l</xref></contrib><contrib contrib-type="author"><name><surname>Vaska</surname><given-names>Paul</given-names></name><xref rid="A2" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><name><surname>Clouston</surname><given-names>Sean A. P.</given-names></name><xref rid="A1" ref-type="aff">a</xref><xref rid="CR1" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><name><surname>Luft</surname><given-names>Benjamin J.</given-names></name><xref rid="A6" ref-type="aff">f</xref><xref rid="A13" ref-type="aff">m</xref></contrib></contrib-group><aff id="A1"><label>a</label>Program in Public Health and Department of Family, Population, and Preventive Medicine, Renaissance School of Medicine at Stony Brook University, Health Sciences Center, 101 Nichols Rd., Stony Brook, NY, USA, 11794</aff><aff id="A2"><label>b</label>Department of Biomedical Engineering, Stony Brook University, Health Sciences Center, 101 Nichols Rd., Stony Brook, NY, USA, 11794</aff><aff id="A3"><label>c</label>Department of Radiology and Imaging Sciences, Emory University, 1364 Clifton Rd., Atlanta, GA, USA, 30322</aff><aff id="A4"><label>d</label>Department of Neurology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1137, New York, NY, USA, 10029</aff><aff id="A5"><label>e</label>Department of Psychiatry and Mount Sinai Alzheimer&#x02019;s Disease Research Center, Icahn School of Medicine at Mount Sinai, 1399 Park Ave., New York, NY, USA, 10029</aff><aff id="A6"><label>f</label>Stony Brook World Trade Center Wellness Program, Renaissance School of Medicine at Stony Brook University, 500 Commack Rd., Stony Brook, NY, USA, 11725</aff><aff id="A7"><label>g</label>The Graduate Center and Queens College, City University of New York, 365 5TH Ave., New York, NY, USA, 10016</aff><aff id="A8"><label>h</label>Department of Environmental Health Sciences, Robert Stempel College of Public Health and Social Work, Florida International University, AHC5, 11200 SW 8th St. #500, Miami, FL, USA, 33174</aff><aff id="A9"><label>i</label>Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA</aff><aff id="A10"><label>j</label>Department of Biomedical, Metabolic and Neurosciences, University of Modena, Via Giuseppe Campi, 287, 41125 Modena MO, Italy</aff><aff id="A11"><label>k</label>Department of Radiology, Northwell Health, 200 West 13th St., 5th Floor, New York, NY, USA, 10011</aff><aff id="A12"><label>l</label>Department of Radiology, Renaissance School of Medicine at Stony Brook University, Health Sciences Center, 101 Nichols Rd., Stony Brook, NY, USA</aff><aff id="A13"><label>m</label>Department of Medicine, Renaissance School of Medicine at Stony Brook University, Health Sciences Center, 101 Nichols Rd., Stony Brook, NY, USA</aff><author-notes><fn fn-type="other" id="FN1"><label>#</label><p id="P1">Co-first authors</p></fn><corresp id="CR1"><label>*</label><bold>Correspondence to</bold> Prof. Sean Clouston, Program in Public Health, 101 Nichols Rd., Health Sciences Center, #3-071, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794, USA. <email>sean.clouston@stonybrookmedicine.edu</email>.</corresp></author-notes><pub-date pub-type="nihms-submitted"><day>26</day><month>6</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>29</day><month>11</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>1</month><year>2026</year></pub-date><volume>103</volume><issue>2</issue><fpage>383</fpage><lpage>395</lpage><abstract id="ABS1"><sec id="S1"><title>Background:</title><p id="P2">B-Amyloid proteins, a hallmark of Alzheimer&#x02019;s disease, are believed to play an adaptive role in the cerebral immune response.</p></sec><sec id="S2"><title>Objective:</title><p id="P3">Noting that cognitive dysfunction, hippocampal inflammation, and hippocampal atrophy are associated with World Trade Center (WTC) exposure duration, we examined whether WTC exposure duration would be associated with cerebral amyloidosis in olfactory regions in WTC responders.</p></sec><sec id="S3"><title>Methods:</title><p id="P4">WTC responders (aged 44&#x02013;65 years) who varied in exposure duration but did not use personalized protective equipment were assessed using positron-emission tomography with [<sup>18</sup>F]-Florbetaben. The outcome was the cortical [<sup>18</sup>F]-Florbetaben burden, measured using regional standardized uptake value ratios (SUVRs) in 34 Desikan-Killiany regions of interest. Spearman&#x02019;s <italic toggle="yes">&#x003c1;</italic>and generalized linear models were used to estimate correlations between WTC exposure duration and cortical [<sup>18</sup>F]-Florbetaben SUVR. Cognitive and behavioral symptoms were measured. Magnetic resonance imaging was used to measure cortical thickness and diffusivity.</p></sec><sec id="S4"><title>Results:</title><p id="P5">The mean age of imaged responders was 56 years old. WTC exposure duration was associated with olfactory [<sup>18</sup>F]-Florbetaben SUVR (Spearman&#x02019;s <italic toggle="yes">&#x003c1;</italic>=0.43, P=0.011), which was in turn associated with elevated [<sup>18</sup>F]-Florbetaben SUVR in ventral regions (<italic toggle="yes">&#x003c1;</italic>=0.41, P=0.016). Cortical [<sup>18</sup>F]-Florbetaben in ventral regions was associated with reduced response speed (<italic toggle="yes">&#x003c1;</italic>=&#x02212;0.72, P&#x0003c;0.001), and was co-located with cortical diffusivity across regions in the parietal and frontal lobes, and with reduced cortical thickness in the isthmus cingulate (<italic toggle="yes">&#x003c1;</italic>=&#x02212;0.53, P=0.001).</p></sec><sec id="S5"><title>Discussion:</title><p id="P6">Low-grade amyloidosis focused on the olfactory and frontal lobes was associated with WTC exposure duration. Future work should examine whether low-grade amyloidosis is correlated with the location or distribution of neurofibrillary tangles in WTC responders.</p></sec></abstract><kwd-group><kwd>Amyloidosis</kwd><kwd>Alzheimer&#x02019;s disease</kwd><kwd>World Trade Center</kwd><kwd>First Responders</kwd><kwd>cognitive impairment</kwd></kwd-group></article-meta></front><body><sec id="S6"><title>Background</title><p id="P7">World Trade Center (WTC) responders were acutely and chronically exposed to neurotoxic chemicals and airborne particulate matter (PM) of varying physical and chemical properties following the terrorist attacks on the WTC on September 11<sup>th</sup>, 2001, which could increase the risk of dementia <sup><xref rid="R1" ref-type="bibr">1</xref></sup>. While they have survived these experiences, this exposure has been found to contain multiple neurotoxic agents including metals, and polychlorinated biphenyls in the dust, and dioxins, solvents, polycyclic aromatic hydrocarbons, acrylonitrile, formaldehyde, and diesel fumes as products of the prolonged jet fuel combustion <sup><xref rid="R2" ref-type="bibr">2</xref></sup>. The initial dust plume from the uncontrolled collapse of the WTC towers engulfed much of lower Manhattan but settled throughout the WTC sites in the following days during which responders had already begun conducting specialized search and rescue projects that lasted for months <sup><xref rid="R3" ref-type="bibr">3</xref></sup>. Since then, studies have reported that highly exposed WTC responders display increased neuroimmune responses both in studies of animals <sup><xref rid="R4" ref-type="bibr">4</xref>, <xref rid="R5" ref-type="bibr">5</xref></sup> and humans <sup><xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref></sup>, alongside changes to serology indicating increased presence of neuropathology <sup><xref rid="R8" ref-type="bibr">8</xref></sup> concurrent with reduced cognitive functioning <sup><xref rid="R9" ref-type="bibr">9</xref>, <xref rid="R10" ref-type="bibr">10</xref></sup> and evidence of neurodegeneration in regions that partially match regions reported in Alzheimer&#x02019;s disease and related dementias (ADRD) <sup><xref rid="R11" ref-type="bibr">11</xref>&#x02013;<xref rid="R13" ref-type="bibr">13</xref></sup>.</p><p id="P8">ADRD is increasingly seen as a heterogeneous condition, with evidence supporting the presence of varying patterns in the burden of cerebral amyloid, co-pathologies present, and symptom type and severity <sup><xref rid="R14" ref-type="bibr">14</xref></sup>. ADRD is also characterized by the presence of increasingly large and dense fibrillary plaques made up of <italic toggle="yes">&#x003b2;</italic>-amyloid (A&#x003b2;) protein in the brain <sup><xref rid="R15" ref-type="bibr">15</xref></sup>. The influence of air pollution on the aging brain has long been a topic of serious inquiry, with several studies suggesting that fine (&#x0003c;2.5&#x003bc;m) PM<sub>2.5</sub> can enter the brain <sup><xref rid="R16" ref-type="bibr">16</xref></sup>. Chronic and severe exposures to inhaled neurotoxic chemicals and airborne particulate matter can maladaptively mobilize the neuroimmune system <sup><xref rid="R17" ref-type="bibr">17</xref></sup> and activate neuroinflammatory responses resulting in ADRD <sup><xref rid="R18" ref-type="bibr">18</xref></sup>. Recent epidemiological studies have shown a greater incidence of dementia associated with higher residential levels of PM<sub>2.5</sub>
<sup><xref rid="R19" ref-type="bibr">19</xref></sup>.</p><p id="P9">A&#x003b2; is central to ADRD but also plays an important role in maintaining homeostasis within the body and brain and is still under investigation. Studies have demonstrated that A&#x003b2; can accumulate centrally as part of neuroimmune responses, particularly to noxious insults, such as short- and long-term viral and microbial infections <sup><xref rid="R20" ref-type="bibr">20</xref>&#x02013;<xref rid="R23" ref-type="bibr">23</xref></sup>. However, a similar process may also be used to respond to air pollution exposure, meaning that A&#x003b2; might arise as part of a homeostatic neuroprotective response to cerebral infiltrate <sup><xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref></sup>. For example, prior work has suggested that a majority of children who are exposed to high levels of aerosolized metals and die in accidents in Mexico City also have evidence of cerebral amyloidosis <sup><xref rid="R24" ref-type="bibr">24</xref></sup>. Animal models support the view that these early responses might grow to become ADRD, suggesting that when subjected to chronic air pollution inhalation animals who displayed strong neuroinflammatory responses <sup><xref rid="R25" ref-type="bibr">25</xref></sup> might also develop cortical and hippocampal atrophy <sup><xref rid="R26" ref-type="bibr">26</xref></sup>.</p><p id="P10">If neurotoxic amyloid plaque formation is associated with inhaled particulate exposures <sup><xref rid="R27" ref-type="bibr">27</xref></sup>, then amyloidosis in the olfactory regions may be a distal outcome of this response <sup><xref rid="R28" ref-type="bibr">28</xref></sup>. Since A&#x003b2; dispersion studies show that A&#x003b2; takes at decades to grow to the levels usually seen in mild cognitive impairment (MCI) <sup><xref rid="R29" ref-type="bibr">29</xref></sup>, we sought to investigate <italic toggle="yes">in-vivo</italic> cortical levels of fibrillar amyloid burden in responders with varying levels of WTC exposure using simultaneous magnetic resonance imaging (MRI) and positron emission tomography (PET) scans, approximately 17 years after the event. This study would enable us to determine whether longer WTC exposure durations could be associated with cerebral amyloid burdens at first in the most affected regions surrounding the point of entry, presumably the olfactory nerves (<xref rid="F1" ref-type="fig">Figure 1</xref>). We hypothesized that the olfactory cortex and surrounding regions would be the locus for the WTC dust infiltration <sup><xref rid="R3" ref-type="bibr">3</xref></sup>, as protruding cilia from the roof of the nasal cavity that separates the frontal lobe could permit the passage of APM particles <sup><xref rid="R30" ref-type="bibr">30</xref></sup>. Furthermore, we theorized that A&#x003b2; burden would also be evident in olfactory-adjacent regions and might also grow in terms of the severity of associated symptoms.</p></sec><sec id="S7"><title>Methods</title><p id="P11">For this study, responders were recruited from individuals attending a clinic-based WTC health monitoring program <sup><xref rid="R31" ref-type="bibr">31</xref>, <xref rid="R32" ref-type="bibr">32</xref></sup> who participated in an epidemiologic study of cognitive aging <sup><xref rid="R33" ref-type="bibr">33</xref></sup>. Responders were included if they had evidence of CI at the time of screening, or if they were cognitively unimpaired (CU) at the time of enrollment. Participants whose case status was not confirmed during screening were excluded. Participants were also eligible if they either had no evidence of post-traumatic stress disorder (PTSD) or if they had chronic PTSD consistently since exposure. Responders were excluded if they had a history of psychosis, severe head trauma from military or WTC response efforts, or diagnosed neurological conditions including stroke, Parkinson&#x02019;s disease, or all-cause dementia where the date of diagnosis is unknown; brain cancer; current renal, liver, or autoimmune disease including multiple sclerosis; heart failure or myocardial infarction in the past year; current use of cognitively active medications; or uncontrolled diabetes. Participants also satisfied the eligibility criteria for MRI scanning (BMI &#x02264; 40, no known claustrophobia, no known metal implants not deemed safe for MRI, and no current pregnancy or breastfeeding). To account for differences between cognitive status groups, we matched groups on age, race/ethnicity, sex, occupation, educational attainment, and chronic (PTSD) status. While not an explicit exclusion criterion, no participants in this study consistently wore personalized protective equipment during their WTC response.</p><sec id="S8"><title>Image Acquisition</title><p id="P12">PET and MRI images were acquired simultaneously on a 3T Siemens Biograph mMR (software version VE11P, Siemens Healthcare, Erlangen, Germany). PET data were acquired from participants 90&#x02013;110 minutes after intravenous injection of 230&#x02013;333 MBq of [<sup>18</sup>F]florbetaben (FBB) radiotracer. [<sup>18</sup>F]-florbetaben was synthesized by Life Molecular, Inc., and delivered to the PET imaging facility at Stony Brook University for all research participants. Three-dimensional volumetric T1-weighted magnetization prepared rapid gradient echo (MPRAGE) images were collected to facilitate PET signal localization and to measure neurodegenerative burden using a vendor-provided 20-channel PET-compatible head/neck coil with TR/TE/TI = 1900/2.49/900 ms; Flip Angle = 9&#x025e6;; acquisition matrix: 256&#x000d7;256; voxel resolution: 0.89 &#x000d7; 0.89 &#x000d7; 0.89 mm.</p><p id="P13">Diffusion tensor imaging was also performed with the following parameters: TE/TR = 87.6/4680 ms, b value = 1200, 64 diffusion directions, in-plane resolution = 2 mm, slice thickness = 2 mm, matrix size = 128 &#x000d7; 128, multiband factor = 2. After data collection, post-processing incorporated standard techniques for acquisition-based artifact elimination. Subject motion and eddy corrections were accounted for using the FMRIB Software Library (FSL) <sup><xref rid="R34" ref-type="bibr">34</xref></sup>.</p><p id="P14">T2-weighted anatomical scans used a turbo spin-echo pulse sequence (34 axial slices, TR=6170s, TE=96ms; Flip angle=150&#x025e6;; acquisition matrix = 320&#x000d7;320; voxel size = 0.36 &#x000d7; 0.36 &#x000d7; 3mm) were acquired and read by a board-certified radiologist to determine incidental findings.</p></sec><sec id="S9"><title>PET Image Reconstruction</title><p id="P15">PET images were reconstructed offline using vendor-provided reconstruction software (e7tools, Siemens Healthcare, Erlangen, Germany). To improve the accuracy of attenuation correction with bone compartment, the &#x0201c;Boston method&#x0201d; was used to generate attenuation maps using the MPRAGE images <sup><xref rid="R35" ref-type="bibr">35</xref></sup>. PET reconstruction was performed using OSEM with point-spread function modeling and 100 iterations (21 subsets) to ensure convergence for optimal quantitative accuracy <sup><xref rid="R36" ref-type="bibr">36</xref></sup>, followed by 4 mm Full-width half maximum (FWHM) Gaussian post-filtering to control noise (effective spatial resolution = 5.1mm) determined using the Joshi method <sup><xref rid="R37" ref-type="bibr">37</xref></sup>.</p></sec><sec id="S10"><title>Image Processing</title><p id="P16">Sinograms were binned covering 20 minutes starting 90 minutes post-injection of [<sup>18</sup>F]-florbetaben according to established protocols <sup><xref rid="R38" ref-type="bibr">38</xref></sup>. PET images were scaled to injected dose and body weight to produce standardized uptake value (SUV) images.</p><p id="P17">Cortical segmentation of the associated T1-MPRAGE images was performed using <italic toggle="yes">FreeSurfer</italic>
<sup><xref rid="R39" ref-type="bibr">39</xref></sup> [V.6.0.0] followed by regional parcellation according to the Desikan-Killiany brain atlas <sup><xref rid="R40" ref-type="bibr">40</xref></sup>. Using the <italic toggle="yes">PETSurfer</italic> tools within <italic toggle="yes">FreeSurfer</italic> we extracted the VOI data from the PET images which also allowed for partial volume correction (PVC) of the VOIs using the Symmetric Geometric Transfer Matrix method <sup><xref rid="R41" ref-type="bibr">41</xref></sup> using the 5.1 mm FWHM resolution determined above.</p><p id="P18">Diffusion images were visually inspected to check for major image artifacts or significant motion during the acquisition. All images passed inspection. No radiological abnormalities were identified in the images. The diffusion data were reconstructed in the Montreal Neurological Institute (MNI) space using q-space diffeomorphic reconstruction <sup><xref rid="R42" ref-type="bibr">42</xref></sup> to obtain the spin distribution function (SDF; diffusion sampling length ratio = 1.25) using DSI Studio (5/4/2019 build) <sup><xref rid="R43" ref-type="bibr">43</xref></sup>. Cortical mean diffusivity (MD; b=0 &#x00026; 1000) is a highly sensitive measure of cortical inflammation <sup><xref rid="R44" ref-type="bibr">44</xref></sup> and microstructural cortical changes <sup><xref rid="R45" ref-type="bibr">45</xref></sup> that often reflects early changes in cerebral structure resulting from amyloidosis. We extracted for a Region of Interest (ROI) based analysis using Desikan-Killiany atlas <sup><xref rid="R40" ref-type="bibr">40</xref></sup> and DSI studios&#x02019; FreeSurferSeg atlas. All 34 unilateral ROI pairs from the Desikan-Killiany atlas <sup><xref rid="R40" ref-type="bibr">40</xref></sup> were studied along with left and right ROI pairs of the hippocampus and amygdala, and five subsections of the corpus callosum from the FreeSurferSeg atlas provided by DSI Studio.</p></sec><sec id="S11"><title><italic toggle="yes">Global Fibrillar [</italic><sup>18</sup>F<italic toggle="yes">]-florbetaben Burden</italic></title><p id="P19">To determine whether potential WTC amyloidosis was similar in cortical topology to that found in AD, we performed a centiloid score analysis of [<sup>18</sup>F]-florbetaben data <sup><xref rid="R46" ref-type="bibr">46</xref></sup>, in which we used PMOD software (PMOD Technologies, Zurich, Switzerland). We strictly followed the protocol for this tracer to calculate a centiloid value for each responder, where centiloid values nominally fall on a 0&#x02013;100 scale such that a centiloid score exceeding 25 can be used as a cutoff for AD positivity <sup><xref rid="R47" ref-type="bibr">47</xref></sup>. The centiloid method provides a universal scaling metric targeted at identifying AD amyloidosis.</p></sec><sec id="S12"><title>Regional Amyloidosis</title><p id="P20">Since [<sup>18</sup>F]-florbetaben distribution in the left and right hemispheres was strongly correlated (r = 0.99), and directions were similar across subregions, regional analyses focused on bilateral abnormalities. We defined three subregions of interest in this study. First, we defined a meta-region consisting of regions near the olfactory bulb and tract including the pars orbitalis, medial orbitofrontal, and lateral orbitofrontal regions. Next, we examined a meta-ROI made up of smaller ROIs that were adjacent to the olfactory bulb and cortex including the accumbens, rostral anterior cingulate, superior frontal, caudal middle frontal, and precentral regions. Finally, a meta-ROI made up of WTC-affected regions identified during a neuroimaging study of WTC responders with early-onset dementia<sup><xref rid="R11" ref-type="bibr">11</xref>, <xref rid="R48" ref-type="bibr">48</xref>, <xref rid="R49" ref-type="bibr">49</xref></sup> consisted of the following regions: hippocampus, entorhinal cortex, parahippocampal gyrus, inferior parietal cortex, inferior/middle/superior temporal gyri (including banks of the superior temporal sulcus), supramarginal gyrus, inferior frontal gyrus, posterior cingulate, isthmus of the cingulate gyrus, precuneus, amygdala, putamen, and ventral diencephalon. All regional SUVs were normalized by the uptake of the whole cerebellum for SUV ratios (SUVR).</p></sec><sec id="S13"><title>PET Image Clinical Read</title><p id="P21">Each [<sup>18</sup>F]-florbetaben image was qualitatively read by a trained analyst (SC) and a board-certified fellowship-trained neuroradiologist with ten years of clinical and research experience in PET/MRI (AF) without knowledge of prior study results or clinical status. The global level of amyloid positivity (positive/negative) and any regional findings were reported.</p><p id="P22"><italic toggle="yes">WTC exposure duration was</italic> assessed using an interview-administered exposure assessment questionnaire that was completed by all responders upon enrollment in the parent monitoring program used to document exposures at the WTC response sites <sup><xref rid="R31" ref-type="bibr">31</xref></sup>. All responders were dust-exposed during the WTC response efforts, so we defined exposure duration as the total duration (in months) of response efforts. None of the imaged responders reported regularly using personalized protective equipment, including masks, while working at the WTC sites.</p></sec><sec id="S14"><title>Clinical Variables:</title><p id="P23">Cognitive Throughput is a corrected response rate measure giving the number of successes per unit of discretionary time and was measured using the CogState<sup>&#x02122;</sup> computerized battery. The battery consisted of five validated game-like tasks (detection, identification, one-card learning, continuous paired associate learning, and Groton maze learning and recall) and was administered to evaluate domains of cognitive dysfunction following a standard operating protocol <sup><xref rid="R50" ref-type="bibr">50</xref></sup>. Across these five tasks, we assessed episodic memory (accuracy measured by the paired associates learning test), visuospatial functioning learning and recall (total errors), visual working memory (accuracy), visuospatial memory, throughput (accurate responses per second), intra-individual item-response variability (measured in standard deviations), processing and response speed (responses per millisecond), and attention (accuracy).</p><p id="P24"><italic toggle="yes">Cognitive status</italic> was determined using the Montreal Cognitive Assessment <sup><xref rid="R51" ref-type="bibr">51</xref></sup>; a cutoff of &#x0003c;22 was used to identify individuals with CI, whereas CU individuals had a score &#x02265;26. Prior work in this population has found that apolipopreotein-&#x003b5;4 (APOE4) status is not a central predictor of cognitive performance, but because this study examined amyloidosis <sup><xref rid="R52" ref-type="bibr">52</xref></sup>, we were able to examine apolipoprotein-&#x003b5;4 (APOE4) allele possession among 28/35 participants who consented to genotype analysis. To accomplish this, deoxyribonucleic acid was extracted from blood samples of WTC responders and genotyped using the Infinium Global Screening Array (Illumina, San Diego, CA, USA), and APOE4 status was recorded. In this small study, none of the participants in this small study were homozygous carriers so we dichotomized the genotype into possessing one allele (actually, only the e3/e4 allele combination was identified) versus non-possession.</p><p id="P25"><italic toggle="yes">Demographics</italic> included age in years, sex (male <italic toggle="yes">versus</italic> female), race/ethnicity (White, Black, Hispanic, and other), educational attainment (high school or less, some college/technical school, and college or more), and occupation on September 11, 2001 (law enforcement <italic toggle="yes">vs.</italic> other) were included as covariates. <italic toggle="yes">Post-traumatic stress disorder</italic> was diagnosed using the Structured Clinical Interview for the DSM-IV (SCID-IV) <sup><xref rid="R53" ref-type="bibr">53</xref></sup>, a semi-structured interview administered by trained clinical interviewers.</p></sec><sec id="S15"><title>Statistical Analysis</title><p id="P26">The sample was described using means and standard deviations, or frequencies and percentages comparing diagnostic categories using non-parametric trend tests and describing qualitative findings. Next, Welch&#x02019;s t-test was used to compare mean tracer uptake in regions previously identified as vulnerable in WTC responders using the WTC regional SUVR and, secondarily, to consider regions commonly examined in AD comparing the Centiloid.</p><p id="P27">The regional distribution of <italic toggle="yes">&#x003b2;</italic>-amyloid used Statistical Parametric Mapping (SPM12) to complete voxel-wise analyses of Gray Matter SUVR completed. All models were adjusted for age, education, and race/ethnicity. Models adjusted for the centiloid score to account for differences in [<sup>18</sup>F]-florbetaben burden predominantly indicative of aging-related sporadic AD. To reduce the potential identification of false positives, p-values were estimated for clusters exceeding 50 voxels in size. FDR-adjusted p-values were estimated for cluster peaks. Results were then mapped onto the cerebral surface using SPM12&#x02019;s Computational Anatomy Toolbox.</p><p id="P28">We compared correlations between WTC exposure duration and tracer uptake in the olfactory and surrounding regions using scatter plots and linear regression. Spearman&#x02019;s <italic toggle="yes">&#x003c1;</italic> was reported for these analyses to account for the potential for nonlinear associations between amyloidosis and potentially correlated features including markers of neurodegeneration and cognitive function. We observed correlations between localized and regional [<sup>18</sup>F]-florbetaben burden, and between [<sup>18</sup>F]-florbetaben burden and cortical atrophy. All models were adjusted for age, education, and race/ethnicity. We also adjusted for the centiloid score to account for differences in [<sup>18</sup>F]-florbetaben burden predominantly indicative of aging-related sporadic AD.</p><p id="P29">A two-tailed &#x003b1; = 0.05 was used to determine statistical significance; results from repeated testing analyses were adjusted for the false discovery rate (FDR = 0.05) <sup><xref rid="R54" ref-type="bibr">54</xref></sup>. Statistical analyses were completed using Stata 17/MP [StataCorp].</p></sec><sec id="S16"><title>Ethics</title><p id="P30">This study was reviewed by the institutional review board. All participants provided informed written consent.</p></sec></sec><sec id="S17"><title>Results</title><sec id="S18"><title>Study Participants</title><p id="P31">In total, 36 participants were deemed ineligible at screening. The 50 remaining individuals were scheduled for neuroimaging, but five withdrew and 9 were unable to complete the neuroimaging visit due to delays or imaging protocol failures (i.e., insufficient radioactive dose, delayed injection past the anticipated injection window, scanner failure). At one appointment, ligand production failed, and the participant refused to try again. These outcomes resulted in a final sample of 35 responders who underwent neuroimaging.</p></sec><sec id="S19"><title>Sample Characteristics</title><p id="P32">We begin by showing the demographic and clinical characteristics of the WTC responder group (<xref rid="T1" ref-type="table">Table 1</xref>). On average, neuroimaging participants were 56 years old, had at least some college, and were trained as first responders. When stratifying the sample into high versus low exposure, we found no statistically significant differences in demographics or other covariates between the two groups.</p></sec><sec id="S20"><title>Group Differences</title><p id="P33">Voxel-wise analyses mapped to the cerebral surface identified elevated amyloid that was generally bilaterally symmetric, presenting with cluster centroids in the medial orbitofrontal, superior frontal, and precentral regions (<xref rid="F2" ref-type="fig">Figure 2</xref>). In this figure, you can see evidence of cortical uptake both in the frontal lobe and in the cingulate, as well as in the left temporal pole and across regions in the parietal lobe. These differences were supplemented by regional analyses showing evidence of [<sup>18</sup>F]-florbetaben retention in WTC-related ROIs (P=0.025), such as the superior temporal and parahippocampal cortices, isthmus cingulate, and hippocampus (<xref rid="SD1" ref-type="supplementary-material">Supplemental Figure 1</xref>).</p></sec><sec id="S21"><title>Clinical Results</title><p id="P34">Qualitative clinical reads assessed one responder as FBB-positive consistent with ADRD (heterozygous apolipoprotein-&#x003b5;3/&#x003b5;4). Three other responders had at least one visual reader indicating the possibility of [<sup>18</sup>F]-florbetaben positivity in one region of interest. Centiloid analysis (mean = &#x02212;9.31, SD = 10.25) identified one responder who met centiloid criteria for the presence of cerebral amyloidosis. Apolipoprotein-&#x003b5;4 allele possession was not associated with amyloidosis in any analysis, though individuals carrying one apolipoprotein-&#x003b5;4 allele had evidence of higher SUVRs in WTC-related regions that might suggest that larger studies would find a difference (APOE- = 1.11, APOE+ = 1.70, difference = 0.60, P=0.16).</p></sec><sec id="S22"><title>[<sup>18</sup>F]-Florbetaben Burden in More Severely Exposed Responders</title><p id="P35">Since WTC responders do not match the topographical [<sup>18</sup>F]-florbetaben burden pattern seen in AD, but rather in ROIs outside centiloid regions, we next focused on WTC susceptible ROIs, such as the olfactory bulb/tract and inferior frontal lobe. Next, we examined associations between WTC exposure duration and [<sup>18</sup>F]-florbetaben retention (<xref rid="F3" ref-type="fig">Figure 3</xref>) to find a positive association between [<sup>18</sup>F]-florbetaben SUVR and longer WTC exposure duration in the olfactory regions (Spearman&#x02019;s <italic toggle="yes">&#x003c1;</italic> =0.43, P=0.011, Panel A). We also identified a significant positive association between olfactory [<sup>18</sup>F]-florbetaben uptake and [<sup>18</sup>F]-florbetaben uptake in neighboring ROIs (<italic toggle="yes">&#x003c1;</italic> =0.93, P&#x0003c;0.001, Panel B), and a significant positive association between [<sup>18</sup>F]-florbetaben uptake in olfactory neighboring ROIs and previously identified WTC ROIs (<italic toggle="yes">&#x003c1;</italic> =0.41, P=0.016, Panel C).</p></sec><sec id="S23"><title>[<sup>18</sup>F]-Florbetaben burden and Neurodegeneration</title><p id="P36">Examinations of ROI-specific associations between tracer uptake and increased cortical mean diffusivity or decreased cortical thickness (<xref rid="T2" ref-type="table">Table 2</xref>) revealed statistically significant increases in cortical mean diffusivity across the entire parietal lobe, and throughout the occipital, temporal, and frontal lobes.</p></sec><sec id="S24"><title><italic toggle="yes">Meta-Regional [</italic><sup>18</sup>F<italic toggle="yes">]-florbetaben Burden and Cognitive Functioning</italic></title><p id="P37">Next, we evaluated associations between cognitive throughput and region-specific [<sup>18</sup>F]-florbetaben burden (<xref rid="T3" ref-type="table">Table 3</xref>). These analyses revealed that Amyloidosis in olfactory-adjacent regions, and the centiloid scores were not associated with measures of cognitive functioning. However, we did find that the amyloid burden measured across the WTC meta-ROI showed statistically significant correlations with cognitive throughput (<italic toggle="yes">&#x003c1;</italic>=&#x02212;0.59), response speed (<italic toggle="yes">&#x003c1;</italic>=&#x02212;0.72), and visuospatial functioning (<italic toggle="yes">&#x003c1;</italic>=&#x02212;0.49) that remained after accounting for multiple comparisons.</p></sec></sec><sec id="S25"><title>Discussion</title><p id="P38">The present study of WTC responders primarily identified cerebral [<sup>18</sup>F]-florbetaben burden, a surrogate <italic toggle="yes">in-vivo</italic> measure of amyloid levels in the brain, that is only partially consistent and therefore distinct from what is typically observed in AD <sup><xref rid="R15" ref-type="bibr">15</xref></sup>. Most studies of Amyloidosis are completed when examining older adults who are experiencing sporadic Alzheimer&#x02019;s disease, which requires enormous amounts of amyloid to cause changes in cognitive functioning. For example, the mean centiloid for patients with Alzheimer&#x02019;s dementia was approximately 84.1 versus 47.5 among those with mild cognitive impairment due to Alzheimer&#x02019;s disease <sup><xref rid="R55" ref-type="bibr">55</xref></sup>. The values shown in this study therefore represent a much lower amyloid burden overall (mean = &#x02212;9.31, SD = 10.25). Additionally, our results specifically implicate a pattern of fibrillary amyloidosis that appears topologically distinct from AD. For example, while most studies of cerebral amyloidosis in Alzheimer&#x02019;s disease report regional elevations throughout the frontal, temporal, and parietal lobes as well as in the precuneus and hippocampus <sup><xref rid="R56" ref-type="bibr">56</xref></sup>, our analyses identified a high A&#x003b2; burden that was bilaterally symmetric, presenting with cluster centroids in the medial orbitofrontal, superior frontal, and precentral regions. Thus, though a growing literature is clear about the critical importance of amyloidosis in Alzheimer&#x02019;s disease, this is the first study to begin to determine the implications of low-grade exposure-related olfactory amyloidosis.</p><p id="P39">When we focused on studying the olfactory regions, we found that amyloidosis was higher in those who were exposed for a longer period. Nevertheless, while this WTC sample seems to be experiencing fibrillar amyloidosis, the hallmark of AD, it seems that those amyloid fibrils are forming topologically differently than in AD. Noting that this might be due to the unique exposures, we hypothesized that the olfactory cortex and neighboring inferior frontal regions would instead be the locus of noxious insults because of inhaling neurotoxic chemicals and materials at the WTC <sup><xref rid="R1" ref-type="bibr">1</xref>, <xref rid="R3" ref-type="bibr">3</xref>, <xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R57" ref-type="bibr">57</xref></sup>. Indeed, inhaling WTC dust containing a mixture of chemicals and particles of ultrafine dimension for months might increase the risk that such particles cross the blood-brain barrier and enter the circulation through blood and cerebrospinal fluid exchange. These results support the view that olfactory and neighboring cortices might serve as one locus of entry for these WTC exposures, with an expectation that symptoms have emerged in the two decades since the event.</p><p id="P40">In this study, the most severely exposed responders, defined using duration (months) spent at the WTC site in our models, were significantly associated with olfactory A&#x003b2; burden and increasing [<sup>18</sup>F]-florbetaben uptake in the neighboring frontal regions. Our models further identified that this A&#x003b2; burden was in turn associated with changes in grey-white matter contrast and cortical thinning of the grey matter ribbon. Furthermore, A&#x003b2; burden was associated with lower neurocognitive scores, such as cognitive response speed and throughput, episodic memory, and visual memory. A&#x003b2; burden in the olfactory region was associated with increased A&#x003b2; burden in proximal ROIs which were in turn associated with lower learning, memory, executive function, and information processing scores <sup><xref rid="R58" ref-type="bibr">58</xref>&#x02013;<xref rid="R62" ref-type="bibr">62</xref></sup>.</p><p id="P41">One interpretation of the presence of a fibrillary A&#x003b2; accumulation in WTC responders could be a possible overactivation of the neuroimmune response <sup><xref rid="R6" ref-type="bibr">6</xref>, <xref rid="R7" ref-type="bibr">7</xref></sup> to noxious insults such as acute or chronic inhalation of neurotoxic air pollutants that could recruit A&#x003b2; as a central part of this process <sup><xref rid="R28" ref-type="bibr">28</xref></sup>. Considering the potential for an immunogenic amyloidosis we hypothesized that the amyloid burden would be greatest in the olfactory regions of the brain because the olfactory bulb would be the most vulnerable to externally inhaled cerebral infiltrate. Our findings support the view that A&#x003b2; burden, as measured by [<sup>18</sup>F]-florbetaben uptake, is present in the olfactory bulb and cortex and that it is associated with amyloidosis in neighboring frontal regions, suggesting that the process of amyloidosis may continue to spread with time. Previous work has suggested that the influence of fibrillary amyloid is predominantly mediated by the presence of tauopathy in older age <sup><xref rid="R27" ref-type="bibr">27</xref></sup> indicating the need for further work studying the intensity of tauopathy in exposed WTC responders.</p><sec id="S26"><title>Strengths and Limitations</title><p id="P42">This study has several limitations including, for example, its small sample size (n=35) and the relatively unique exposures this population endured. The small sample size can cause several problems including a reduced ability to thoroughly map the full clusters of cerebral amyloidosis, and a reduced ability to identify correlations between amyloid and cognitive performance levels. Exposures at the WTC are like air pollution exposures, but the chemical mix is potentially unique and may therefore be generalizable to other occupational studies on disaster responses, where buildings are destroyed or burned unexpectedly or because of war conflicts, or also to the impact of climate-induced wildfires. Prior results from this population are consistent with mouse models and other <italic toggle="yes">in vivo</italic> studies of brain structure in people exposed to high levels of air pollution globally <sup><xref rid="R3" ref-type="bibr">3</xref>&#x02013;<xref rid="R5" ref-type="bibr">5</xref>, <xref rid="R57" ref-type="bibr">57</xref></sup>. We cannot determine whether these results align, since WTC dust contained a potentially unique mixture of neurotoxins, or whether the presence of any PM2.5 at the WTC was amenable to cerebral infiltration was sufficient. While our study included predominantly male subjects, this distribution matches our population as a whole and the makeup of WTC first responders in general. Finally, while the Alzheimer&#x02019;s disease pathological cascade is believed to cause cerebral amyloidosis before the distribution of cerebral tauopathy and neurodegeneration, in this study we reported that cerebral amyloidosis is associated with both cognitive dysfunction and indicators of cortical atrophy. Future research is needed to assess the extent to which cerebral tauopathy is evident in this potentially novel condition.</p></sec><sec id="S27"><title>Conclusions</title><p id="P43">WTC exposures included severe inhaled exposure to fine particulate matter as well as air pollutants like polycyclic aromatic hydrocarbons and dioxins. In this study, we found that responders who were exposed to the WTC worksites for months and who did not wear personalized protective equipment had a heightened burden of amyloidosis in the olfactory cortex as compared to those individuals with reduced lengths of exposure. Cerebral amyloidosis is concerning because it implies the presence of aging-related amyloidosis at younger ages. Such findings imply that exposure to air pollution may be a cause of a novel form of neuropathology in severely and chronically exposed individuals. If true, then efforts to remediate workplace exposures and protect workers might reduce the long-term burden of dementia in the population.</p></sec></sec><sec sec-type="supplementary-material" id="SM1"><title>Supplementary Material</title><supplementary-material id="SD1" position="float" content-type="local-data"><label>Appendices</label><media xlink:href="NIHMS2086140-supplement-Appendices.docx" id="d67e835" position="anchor"/></supplementary-material></sec></body><back><ack id="S28"><title>Acknowledgements:</title><p id="P44">We would like to acknowledge all WTC responders, their efforts and service, and their participation in our research studies.</p><sec id="S29"><title>Funding:</title><p id="P45">The authors would like to acknowledge support from the Centers for Disease Control and Prevention (CDC/NIOSH U01 OH011314; and CDC 200&#x02013;2011-39361), the National Institute on Aging (NIH/NIA R01 AG049953; NIH/NIA P30 AG066514).</p></sec><sec sec-type="COI-statement" id="S30"><title>Conflict of interest statement:</title><p id="P46">Dr. Gandy is a co-founder of Recuerdo Pharmaceuticals. He has served as a consultant in the past for J&#x00026;J, Diagenic, and Pfizer, and he currently consults for Cognito Therapeutics, GLG Group, SVB Securities, Guidepoint, Third Bridge, MEDACORP, Altpep, Vigil Neurosciences, and Eisai. He has received research support in the past from Warner-Lambert, Pfizer, Baxter, and Avid. He currently receives research support from the NIH and the Cure Alzheimer&#x02019;s Fund. Dr. Franceschi has served as consultant for Biogen, Life Molecular Imaging, Roche/Genentech, and Eisai. No other authors have conflicts of interest to disclose. Sean Clouston is an Editorial Board Member of this journal but was not involved in the peer-review process of this article nor had access to any information regarding its peer review.</p></sec></ack><fn-group><fn id="FN2"><p id="P48"><bold>Consent Statement:</bold> The study was reviewed by the institutional review board (CORIHS #1315306). All participants provided informed written consent.</p></fn></fn-group><sec sec-type="data-availability" id="S31"><title>Data Availability:</title><p id="P47">The data supporting the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy restrictions.</p></sec><ref-list><title>References</title><ref id="R1"><label>1.</label><mixed-citation publication-type="journal"><name><surname>Clouston</surname><given-names>SAP</given-names></name>, <name><surname>Hall</surname><given-names>CB</given-names></name>, <name><surname>Kritikos</surname><given-names>M</given-names></name>, <etal/>
<article-title>Cognitive impairment and World Trade Centre-related exposures</article-title>. <source>Nat Rev Neurol</source>
<year>2022</year>; <volume>18</volume>: <fpage>103</fpage>&#x02013;<lpage>116</lpage>. . DOI: <pub-id pub-id-type="doi">10.1038/s41582-021-00576-8</pub-id>.<pub-id pub-id-type="pmid">34795448</pub-id>
</mixed-citation></ref><ref id="R2"><label>2.</label><mixed-citation publication-type="journal"><name><surname>Lioy</surname><given-names>PJ</given-names></name>, <name><surname>Weisel</surname><given-names>CP</given-names></name>, <name><surname>Millette</surname><given-names>JR</given-names></name>, <etal/>
<article-title>Characterization of the dust/smoke aerosol that settled east of the World Trade Center (WTC) in lower Manhattan after the collapse of the WTC 11 September 2001</article-title>. <source>Environ Health Perspect</source>
<year>2002</year>; <volume>110</volume>: <fpage>703</fpage>&#x02013;<lpage>714</lpage>. 2002/07/16. DOI: <pub-id pub-id-type="doi">10.1289/ehp.02110703</pub-id>.<pub-id pub-id-type="pmid">12117648</pub-id>
</mixed-citation></ref><ref id="R3"><label>3.</label><mixed-citation publication-type="journal"><name><surname>Kritikos</surname><given-names>M</given-names></name>, <name><surname>Gandy</surname><given-names>SE</given-names></name>, <name><surname>Meliker</surname><given-names>JR</given-names></name>, <etal/>
<article-title>Acute versus Chronic Exposures to Inhaled Particulate Matter and Neurocognitive Dysfunction: Pathways to Alzheimer&#x02019;s Disease or a Related Dementia</article-title>. <source>J Alzheimers Dis</source>
<year>2020</year>; <volume>78</volume>: <fpage>871</fpage>&#x02013;<lpage>886</lpage>. 2020/10/20. DOI: <pub-id pub-id-type="doi">10.3233/JAD-200679</pub-id>.<pub-id pub-id-type="pmid">33074229</pub-id>
</mixed-citation></ref><ref id="R4"><label>4.</label><mixed-citation publication-type="journal"><name><surname>Iban-Arias</surname><given-names>R</given-names></name>, <name><surname>Trageser</surname><given-names>KJ</given-names></name>, <name><surname>Yang</surname><given-names>E-J</given-names></name>, <etal/>
<article-title>Exposure to world trade center dust exacerbates cognitive impairment and evokes a central and peripheral pro-inflammatory transcriptional profile in an animal model of alzheimer&#x02019;s disease</article-title>. <source>Journal of Alzheimer&#x02019;s Disease</source>
<year>2023</year>; <volume>91</volume>: <fpage>779</fpage>&#x02013;<lpage>794</lpage>.</mixed-citation></ref><ref id="R5"><label>5.</label><mixed-citation publication-type="journal"><name><surname>Hernandez</surname><given-names>M</given-names></name>, <name><surname>Vaughan</surname><given-names>J</given-names></name>, <name><surname>Gordon</surname><given-names>T</given-names></name>, <etal/>
<article-title>World Trade Center dust induces nasal and neurological tissue injury while propagating reduced olfaction capabilities and increased anxiety behaviors</article-title>. <source>Inhalation Toxicology</source>
<year>2022</year>; <volume>34</volume>: <fpage>175</fpage>&#x02013;<lpage>188</lpage>. DOI: <pub-id pub-id-type="doi">10.1080/08958378.2022.2072027</pub-id>.<pub-id pub-id-type="pmid">35533138</pub-id>
</mixed-citation></ref><ref id="R6"><label>6.</label><mixed-citation publication-type="journal"><name><surname>Kuan</surname><given-names>PF</given-names></name>, <name><surname>Clouston</surname><given-names>S</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>, <etal/>
<article-title>Single-cell transcriptomics analysis of mild cognitive impairment in World Trade Center disaster responders</article-title>. <source>Alzheimers Dement (Amst)</source>
<year>2021</year>; <volume>13</volume>: <fpage>e12154</fpage>. 20210220. DOI: <pub-id pub-id-type="doi">10.1002/dad2.12154</pub-id>.<pub-id pub-id-type="pmid">33665344</pub-id>
</mixed-citation></ref><ref id="R7"><label>7.</label><mixed-citation publication-type="journal"><name><surname>Deri</surname><given-names>Y</given-names></name>, <name><surname>Clouston</surname><given-names>SAP</given-names></name>, <name><surname>DeLorenzo</surname><given-names>C</given-names></name>, <etal/>
<article-title>Neuroinflammation in World Trade Center responders at midlife: A pilot study using [(18)F]-FEPPA PET imaging</article-title>. <source>Brain Behav Immun Health</source>
<year>2021</year>; <volume>16</volume>: <fpage>100287</fpage>. 20210630. DOI: <pub-id pub-id-type="doi">10.1016/j.bbih.2021.100287</pub-id>.<pub-id pub-id-type="pmid">34589784</pub-id>
</mixed-citation></ref><ref id="R8"><label>8.</label><mixed-citation publication-type="journal"><name><surname>Kritikos</surname><given-names>M</given-names></name>, <name><surname>Diminich</surname><given-names>ED</given-names></name>, <name><surname>Meliker</surname><given-names>J</given-names></name>, <etal/>
<article-title>Plasma amyloid beta 40/42, phosphorylated tau 181, and neurofilament light are associated with cognitive impairment and neuropathological changes among World Trade Center responders: A prospective cohort study of exposures and cognitive aging at midlife</article-title>. <source>Alzheimers Dement (Amst)</source>
<year>2023</year>; <volume>15</volume>: <fpage>e12409</fpage>. 20230308. DOI: <pub-id pub-id-type="doi">10.1002/dad2.12409</pub-id>.<pub-id pub-id-type="pmid">36911360</pub-id>
</mixed-citation></ref><ref id="R9"><label>9.</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Y</given-names></name>, <name><surname>Natale</surname><given-names>G</given-names></name> and <name><surname>Clouston</surname><given-names>SAP</given-names></name>. <article-title>Incidence of Mild Cognitive Impairment, Conversion to Probable Dementia, and Mortality</article-title>. <source>American Journal of Alzheimer&#x02019;s Disease &#x00026; Other Dementias<sup>&#x000ae;</sup></source>
<year>2021</year>; <volume>36</volume>: <fpage>15333175211012235</fpage>. DOI: <pub-id pub-id-type="doi">10.1177/15333175211012235</pub-id>.</mixed-citation></ref><ref id="R10"><label>10.</label><mixed-citation publication-type="journal"><name><surname>Clouston</surname><given-names>SAP</given-names></name>, <name><surname>Diminich</surname><given-names>ED</given-names></name>, <name><surname>Kotov</surname><given-names>R</given-names></name>, <etal/>
<article-title>Incidence of mild cognitive impairment in World Trade Center responders: Long-term consequences of re-experiencing the events on 9/11/2001</article-title>. <source>Alzheimers Dement (Amst)</source>
<year>2019</year>; <volume>11</volume>: <fpage>628</fpage>&#x02013;<lpage>636</lpage>. 20190906. DOI: <pub-id pub-id-type="doi">10.1016/j.dadm.2019.07.006</pub-id>.<pub-id pub-id-type="pmid">31517025</pub-id>
</mixed-citation></ref><ref id="R11"><label>11.</label><mixed-citation publication-type="journal"><name><surname>Clouston</surname><given-names>S</given-names></name>, <name><surname>Deri</surname><given-names>Y</given-names></name>, <name><surname>Horton</surname><given-names>M</given-names></name>, <etal/>
<article-title>Reduced cortical thickness in World Trade Center responders with cognitive impairment: Neuroimaging/differential diagnosis</article-title>. <source>Alzheimer&#x02019;s &#x00026; Dementia</source>
<year>2020</year>; <volume>16</volume>: <fpage>e039996</fpage>.</mixed-citation></ref><ref id="R12"><label>12.</label><mixed-citation publication-type="journal"><name><surname>Clouston</surname><given-names>SAP</given-names></name>, <name><surname>Kritikos</surname><given-names>M</given-names></name>, <name><surname>Deri</surname><given-names>Y</given-names></name>, <etal/>
<article-title>A cortical thinning signature to identify World Trade Center responders with possible dementia</article-title>. <source>Intelligence-Based Medicine</source>
<year>2021</year>; <volume>5</volume>: <fpage>100032</fpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.ibmed.2021.100032</pub-id>.<pub-id pub-id-type="pmid">35991958</pub-id>
</mixed-citation></ref><ref id="R13"><label>13.</label><mixed-citation publication-type="journal"><name><surname>Clouston</surname><given-names>SAP</given-names></name>, <name><surname>Kritikos</surname><given-names>M</given-names></name>, <name><surname>Huang</surname><given-names>C</given-names></name>, <etal/>
<article-title>Reduced cerebellar cortical thickness in World Trade Center responders with cognitive impairment</article-title>. <source>Transl Psychiatry</source>
<year>2022</year>; <volume>12</volume>: <fpage>107</fpage>. 20220316. DOI: <pub-id pub-id-type="doi">10.1038/s41398-022-01873-6</pub-id>.<pub-id pub-id-type="pmid">35296637</pub-id>
</mixed-citation></ref><ref id="R14"><label>14.</label><mixed-citation publication-type="journal"><name><surname>Jellinger</surname><given-names>KA</given-names></name>. <article-title>Recent update on the heterogeneity of the Alzheimer&#x02019;s disease spectrum</article-title>. <source>Journal of Neural Transmission</source>
<year>2022</year>; <volume>129</volume>: <fpage>1</fpage>&#x02013;<lpage>24</lpage>.<pub-id pub-id-type="pmid">34919190</pub-id>
</mixed-citation></ref><ref id="R15"><label>15.</label><mixed-citation publication-type="journal"><name><surname>Jack</surname><given-names>CR</given-names><suffix>Jr.</suffix></name>, <name><surname>Bennett</surname><given-names>DA</given-names></name>, <name><surname>Blennow</surname><given-names>K</given-names></name>, <etal/>
<article-title>NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x02019;s disease</article-title>. <source>Alzheimers Dement</source>
<year>2018</year>; <volume>14</volume>: <fpage>535</fpage>&#x02013;<lpage>562</lpage>. 2018/04/15. DOI: <pub-id pub-id-type="doi">10.1016/j.jalz.2018.02.018</pub-id>.<pub-id pub-id-type="pmid">29653606</pub-id>
</mixed-citation></ref><ref id="R16"><label>16.</label><mixed-citation publication-type="journal"><name><surname>Calder&#x000f3;n-Garcidue&#x000f1;as</surname><given-names>L</given-names></name> and <name><surname>Ayala</surname><given-names>A</given-names></name>. <article-title>Air Pollution, Ultrafine Particles, and Your Brain: Are Combustion Nanoparticle Emissions and Engineered Nanoparticles Causing Preventable Fatal Neurodegenerative Diseases and Common Neuropsychiatric Outcomes?</article-title>
<source>Environmental Science &#x00026; Technology</source>
<year>2022</year>; <volume>56</volume>: <fpage>6847</fpage>&#x02013;<lpage>6856</lpage>. DOI: <pub-id pub-id-type="doi">10.1021/acs.est.1c04706</pub-id>.<pub-id pub-id-type="pmid">35193357</pub-id>
</mixed-citation></ref><ref id="R17"><label>17.</label><mixed-citation publication-type="journal"><name><surname>Wainberg</surname><given-names>M</given-names></name>, <name><surname>Luquez</surname><given-names>T</given-names></name>, <name><surname>Koelle</surname><given-names>DM</given-names></name>, <etal/>
<article-title>The viral hypothesis: how herpesviruses may contribute to Alzheimer&#x02019;s disease</article-title>. <source>Mol Psychiatry</source>
<year>2021</year>; <volume>26</volume>: <fpage>5476</fpage>&#x02013;<lpage>5480</lpage>. 20210510. DOI: <pub-id pub-id-type="doi">10.1038/s41380-021-01138-6</pub-id>.<pub-id pub-id-type="pmid">33972690</pub-id>
</mixed-citation></ref><ref id="R18"><label>18.</label><mixed-citation publication-type="journal"><name><surname>Livingston</surname><given-names>G</given-names></name>, <name><surname>Huntley</surname><given-names>J</given-names></name>, <name><surname>Sommerlad</surname><given-names>A</given-names></name>, <etal/>
<article-title>Dementia prevention, intervention, and care: 2020 report of the Lancet Commission</article-title>. <source>Lancet</source>
<year>2020</year>; <volume>396</volume>: <fpage>413</fpage>&#x02013;<lpage>446</lpage>. 20200730. DOI: <pub-id pub-id-type="doi">10.1016/S0140-6736(20)30367-6</pub-id>.<pub-id pub-id-type="pmid">32738937</pub-id>
</mixed-citation></ref><ref id="R19"><label>19.</label><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>B</given-names></name>, <name><surname>Weuve</surname><given-names>J</given-names></name>, <name><surname>Langa</surname><given-names>KM</given-names></name>, <etal/>
<article-title>Comparison of particulate air pollution from different emission sources and incident dementia in the US</article-title>. <source>JAMA Internal Medicine</source>
<year>2023</year>.</mixed-citation></ref><ref id="R20"><label>20.</label><mixed-citation publication-type="journal"><name><surname>Wozniak</surname><given-names>MA</given-names></name>, <name><surname>Itzhaki</surname><given-names>RF</given-names></name>, <name><surname>Shipley</surname><given-names>SJ</given-names></name>, <etal/>
<article-title>Herpes simplex virus infection causes cellular &#x003b2;-amyloid accumulation and secretase upregulation</article-title>. <source>Neuroscience letters</source>
<year>2007</year>; <volume>429</volume>: <fpage>95</fpage>&#x02013;<lpage>100</lpage>.<pub-id pub-id-type="pmid">17980964</pub-id>
</mixed-citation></ref><ref id="R21"><label>21.</label><mixed-citation publication-type="journal"><name><surname>Eimer</surname><given-names>WA</given-names></name>, <name><surname>Kumar</surname><given-names>DKV</given-names></name>, <name><surname>Shanmugam</surname><given-names>NKN</given-names></name>, <etal/>
<article-title>Alzheimer&#x02019;s disease-associated &#x003b2;-amyloid is rapidly seeded by herpesviridae to protect against brain infection</article-title>. <source>Neuron</source>
<year>2018</year>; <volume>99</volume>: <fpage>56</fpage>&#x02013;<lpage>63</lpage>. e53.<pub-id pub-id-type="pmid">30001512</pub-id>
</mixed-citation></ref><ref id="R22"><label>22.</label><mixed-citation publication-type="journal"><name><surname>Soscia</surname><given-names>SJ</given-names></name>, <name><surname>Kirby</surname><given-names>JE</given-names></name>, <name><surname>Washicosky</surname><given-names>KJ</given-names></name>, <etal/>
<article-title>The Alzheimer&#x02019;s disease-associated amyloid &#x003b2;-protein is an antimicrobial peptide</article-title>. <source>Plos One</source>
<year>2010</year>; <volume>5</volume>: <fpage>e9505</fpage>.<pub-id pub-id-type="pmid">20209079</pub-id>
</mixed-citation></ref><ref id="R23"><label>23.</label><mixed-citation publication-type="journal"><name><surname>Readhead</surname><given-names>B</given-names></name>, <name><surname>Haure-Mirande</surname><given-names>J-V</given-names></name>, <name><surname>Funk</surname><given-names>CC</given-names></name>, <etal/>
<article-title>Multiscale analysis of independent Alzheimer&#x02019;s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus</article-title>. <source>Neuron</source>
<year>2018</year>; <volume>99</volume>: <fpage>64</fpage>&#x02013;<lpage>82</lpage>. e67.<pub-id pub-id-type="pmid">29937276</pub-id>
</mixed-citation></ref><ref id="R24"><label>24.</label><mixed-citation publication-type="journal"><name><surname>Calder&#x000f3;n-Garcidue&#x000f1;as</surname><given-names>L</given-names></name>, <name><surname>Torres-Jard&#x000f3;n</surname><given-names>R</given-names></name>, <name><surname>Kulesza</surname><given-names>RJ</given-names></name>, <etal/>
<article-title>Alzheimer disease starts in childhood in polluted Metropolitan Mexico City. A major health crisis in progress</article-title>. <source>Environmental Research</source>
<year>2020</year>; <volume>183</volume>: <fpage>109137</fpage>. DOI: <pub-id pub-id-type="doi">10.1016/j.envres.2020.109137</pub-id>.<pub-id pub-id-type="pmid">32006765</pub-id>
</mixed-citation></ref><ref id="R25"><label>25.</label><mixed-citation publication-type="journal"><name><surname>Cheng</surname><given-names>H</given-names></name>, <name><surname>Saffari</surname><given-names>A</given-names></name>, <name><surname>Sioutas</surname><given-names>C</given-names></name>, <etal/>
<article-title>Nanoscale Particulate Matter from Urban Traffic Rapidly Induces Oxidative Stress and Inflammation in Olfactory Epithelium with Concomitant Effects on Brain</article-title>. <source>Environ Health Perspect</source>
<year>2016</year>; <volume>124</volume>: <fpage>1537</fpage>&#x02013;<lpage>1546</lpage>. 20160517. DOI: <pub-id pub-id-type="doi">10.1289/EHP134</pub-id>.<pub-id pub-id-type="pmid">27187980</pub-id>
</mixed-citation></ref><ref id="R26"><label>26.</label><mixed-citation publication-type="journal"><name><surname>Haghani</surname><given-names>A</given-names></name>, <name><surname>Morgan</surname><given-names>TE</given-names></name>, <name><surname>Forman</surname><given-names>HJ</given-names></name>, <etal/>
<article-title>Air Pollution Neurotoxicity in the Adult Brain: Emerging Concepts from Experimental Findings</article-title>. <source>Journal of Alzheimer&#x02019;s Disease</source>
<year>2020</year>; <volume>76</volume>: <fpage>773</fpage>&#x02013;<lpage>797</lpage>. DOI: <pub-id pub-id-type="doi">10.3233/JAD-200377</pub-id>.</mixed-citation></ref><ref id="R27"><label>27.</label><mixed-citation publication-type="journal"><name><surname>Wilson</surname><given-names>RS</given-names></name>, <name><surname>Arnold</surname><given-names>SE</given-names></name>, <name><surname>Schneider</surname><given-names>JA</given-names></name>, <etal/>
<article-title>The relationship between cerebral Alzheimer&#x02019;s disease pathology and odour identification in old age</article-title>. <source>J Neurol Neurosurg Psychiatry</source>
<year>2007</year>; <volume>78</volume>: <fpage>30</fpage>&#x02013;<lpage>35</lpage>. 20060929. DOI: <pub-id pub-id-type="doi">10.1136/jnnp.2006.099721</pub-id>.<pub-id pub-id-type="pmid">17012338</pub-id>
</mixed-citation></ref><ref id="R28"><label>28.</label><mixed-citation publication-type="journal"><name><surname>Cacciottolo</surname><given-names>M</given-names></name>, <name><surname>Morgan</surname><given-names>TE</given-names></name>, <name><surname>Saffari</surname><given-names>AA</given-names></name>, <etal/>
<article-title>Traffic-related air pollutants (TRAP-PM) promote neuronal amyloidogenesis through oxidative damage to lipid rafts</article-title>. <source>Free Radical Biology and Medicine</source>
<year>2020</year>; <volume>147</volume>: <fpage>242</fpage>&#x02013;<lpage>251</lpage>.<pub-id pub-id-type="pmid">31883973</pub-id>
</mixed-citation></ref><ref id="R29"><label>29.</label><mixed-citation publication-type="journal"><name><surname>Jagust</surname><given-names>WJ</given-names></name>, <name><surname>Landau</surname><given-names>SM</given-names></name>and <collab>Alzheimer&#x02019;s Disease Neuroimaging Initiative (ADNI).</collab>
<article-title>Temporal Dynamics of &#x003b2;-Amyloid Accumulation in Aging and Alzheimer Disease</article-title>. <source>Neurology</source>
<year>2021</year>; <volume>96</volume>: <fpage>e1347</fpage>&#x02013;<lpage>e1357</lpage>. DOI: doi:<pub-id pub-id-type="doi">10.1212/WNL.0000000000011524</pub-id>.<pub-id pub-id-type="pmid">33408147</pub-id>
</mixed-citation></ref><ref id="R30"><label>30.</label><mixed-citation publication-type="book"><name><surname>Branigan B</surname><given-names>TPP</given-names></name>, <part-title>Olfactory. . Physiology, Olfactory</part-title>. . In: <source>StatPearls</source> [Internet]. <publisher-loc>Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>; <year>2023</year></mixed-citation></ref><ref id="R31"><label>31.</label><mixed-citation publication-type="journal"><name><surname>Dasaro</surname><given-names>CR</given-names></name>, <name><surname>Holden</surname><given-names>WL</given-names></name>, <name><surname>Berman</surname><given-names>KD</given-names></name>, <etal/>
<article-title>Cohort Profile: World Trade Center Health Program General Responder Cohort</article-title>. <source>Int J Epidemiol</source>
<year>2017</year>; <volume>46</volume>: <fpage>e9</fpage>. 2015/06/22. DOI: <pub-id pub-id-type="doi">10.1093/ije/dyv099</pub-id>.<pub-id pub-id-type="pmid">26094072</pub-id>
</mixed-citation></ref><ref id="R32"><label>32.</label><mixed-citation publication-type="journal"><name><surname>Luft</surname><given-names>BJ</given-names></name>, <name><surname>Schechter</surname><given-names>C</given-names></name>, <name><surname>Kotov</surname><given-names>R</given-names></name>, <etal/>
<article-title>Exposure, probable PTSD and lower respiratory illness among World Trade Center rescue, recovery and clean-up workers</article-title>. <source>Psychol Med</source>
<year>2012</year>; <volume>42</volume>: <fpage>1069</fpage>&#x02013;<lpage>1079</lpage>. 2012/03/31. DOI: <pub-id pub-id-type="doi">10.1017/S003329171100256X</pub-id>.<pub-id pub-id-type="pmid">22459506</pub-id>
</mixed-citation></ref><ref id="R33"><label>33.</label><mixed-citation publication-type="journal"><name><surname>Clouston</surname><given-names>SA</given-names></name>, <name><surname>Kotov</surname><given-names>R</given-names></name>, <name><surname>Pietrzak</surname><given-names>RH</given-names></name>, <etal/>
<article-title>Cognitive impairment among World Trade Center responders: Long-term implications of re-experiencing the 9/11 terrorist attacks</article-title>. <source>Alzheimers Dement (Amst)</source>
<year>2016</year>; <volume>4</volume>: <fpage>67</fpage>&#x02013;<lpage>75</lpage>. 20160819. DOI: <pub-id pub-id-type="doi">10.1016/j.dadm.2016.08.001</pub-id>.<pub-id pub-id-type="pmid">27626057</pub-id>
</mixed-citation></ref><ref id="R34"><label>34.</label><mixed-citation publication-type="journal"><name><surname>Jenkinson</surname><given-names>M</given-names></name>, <name><surname>Beckmann</surname><given-names>CF</given-names></name>, <name><surname>Behrens</surname><given-names>TE</given-names></name>, <etal/>
<article-title>Fsl</article-title>. <source>Neuroimage</source>
<year>2012</year>; <volume>62</volume>: <fpage>782</fpage>&#x02013;<lpage>790</lpage>. 2011/10/08. DOI: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.09.015</pub-id>.<pub-id pub-id-type="pmid">21979382</pub-id>
</mixed-citation></ref><ref id="R35"><label>35.</label><mixed-citation publication-type="journal"><name><surname>Izquierdo-Garcia</surname><given-names>D</given-names></name>, <name><surname>Hansen</surname><given-names>AE</given-names></name>, <name><surname>Forster</surname><given-names>S</given-names></name>, <etal/>
<article-title>An SPM8-based approach for attenuation correction combining segmentation and nonrigid template formation: application to simultaneous PET/MR brain imaging</article-title>. <source>J Nucl Med</source>
<year>2014</year>; <volume>55</volume>: <fpage>1825</fpage>&#x02013;<lpage>1830</lpage>. DOI: <pub-id pub-id-type="doi">10.2967/jnumed.113.136341</pub-id>.<pub-id pub-id-type="pmid">25278515</pub-id>
</mixed-citation></ref><ref id="R36"><label>36.</label><mixed-citation publication-type="journal"><name><surname>Lantos</surname><given-names>J</given-names></name>, <name><surname>Mittra</surname><given-names>ES</given-names></name>, <name><surname>Levin</surname><given-names>CS</given-names></name>, <etal/>
<article-title>Standard OSEM vs. regularized PET image reconstruction: qualitative and quantitative comparison using phantom data and various clinical radiopharmaceuticals</article-title>. <source>Am J Nucl Med Mol Imaging</source>
<year>2018</year>; <volume>8</volume>: <fpage>110</fpage>&#x02013;<lpage>118</lpage>. 20180425.<pub-id pub-id-type="pmid">29755844</pub-id>
</mixed-citation></ref><ref id="R37"><label>37.</label><mixed-citation publication-type="journal"><name><surname>Joshi</surname><given-names>A</given-names></name>, <name><surname>Koeppe</surname><given-names>RA</given-names></name> and <name><surname>Fessler</surname><given-names>JA</given-names></name>. <article-title>Reducing between scanner differences in multi-center PET studies</article-title>. <source>Neuroimage</source>
<year>2009</year>; <volume>46</volume>: <fpage>154</fpage>&#x02013;<lpage>159</lpage>. 2009/05/22. DOI: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2009.01.057</pub-id>.<pub-id pub-id-type="pmid">19457369</pub-id>
</mixed-citation></ref><ref id="R38"><label>38.</label><mixed-citation publication-type="journal"><name><surname>Bullich</surname><given-names>S</given-names></name>, <name><surname>Seibyl</surname><given-names>J</given-names></name>, <name><surname>Catafau</surname><given-names>AM</given-names></name>, <etal/>
<article-title>Optimized classification of (18)F-Florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment</article-title>. <source>Neuroimage Clin</source>
<year>2017</year>; <volume>15</volume>: <fpage>325</fpage>&#x02013;<lpage>332</lpage>. 2017/06/01. DOI: <pub-id pub-id-type="doi">10.1016/j.nicl.2017.04.025</pub-id>.<pub-id pub-id-type="pmid">28560157</pub-id>
</mixed-citation></ref><ref id="R39"><label>39.</label><mixed-citation publication-type="journal"><name><surname>Fischl</surname><given-names>B</given-names></name>. <article-title>FreeSurfer</article-title>. <source>Neuroimage</source>
<year>2012</year>; <volume>62</volume>: <fpage>774</fpage>&#x02013;<lpage>781</lpage>. 2012/01/18. DOI: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2012.01.021</pub-id>.<pub-id pub-id-type="pmid">22248573</pub-id>
</mixed-citation></ref><ref id="R40"><label>40.</label><mixed-citation publication-type="journal"><name><surname>Desikan</surname><given-names>RS</given-names></name>, <name><surname>S&#x000e9;gonne</surname><given-names>F</given-names></name>, <name><surname>Fischl</surname><given-names>B</given-names></name>, <etal/>
<article-title>An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest</article-title>. <source>Neuroimage</source>
<year>2006</year>; <volume>31</volume>: <fpage>968</fpage>&#x02013;<lpage>980</lpage>.<pub-id pub-id-type="pmid">16530430</pub-id>
</mixed-citation></ref><ref id="R41"><label>41.</label><mixed-citation publication-type="journal"><name><surname>Sattarivand</surname><given-names>M</given-names></name>, <name><surname>Kusano</surname><given-names>M</given-names></name>, <name><surname>Poon</surname><given-names>I</given-names></name>, <etal/>
<article-title>Symmetric geometric transfer matrix partial volume correction for PET imaging: principle, validation and robustness</article-title>. <source>Phys Med Biol</source>
<year>2012</year>; <volume>57</volume>: <fpage>7101</fpage>&#x02013;<lpage>7116</lpage>. 20121010. DOI: <pub-id pub-id-type="doi">10.1088/0031-9155/57/21/7101</pub-id>.<pub-id pub-id-type="pmid">23051703</pub-id>
</mixed-citation></ref><ref id="R42"><label>42.</label><mixed-citation publication-type="journal"><name><surname>Yeh</surname><given-names>F-C</given-names></name> and <name><surname>Tseng</surname><given-names>W-YI</given-names></name>. <article-title>NTU-90: a high angular resolution brain atlas constructed by q-space diffeomorphic reconstruction</article-title>. <source>Neuroimage</source>
<year>2011</year>; <volume>58</volume>: <fpage>91</fpage>&#x02013;<lpage>99</lpage>. 20110616. DOI: <pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.06.021</pub-id>.<pub-id pub-id-type="pmid">21704171</pub-id>
</mixed-citation></ref><ref id="R43"><label>43.</label><mixed-citation publication-type="journal"><name><surname>Yeh</surname><given-names>F-C</given-names></name>, <name><surname>Wedeen</surname><given-names>VJ</given-names></name> and <name><surname>Tseng</surname><given-names>W-YI</given-names></name>. <article-title>Generalized ${q} $-sampling imaging</article-title>. <source>IEEE transactions on medical imaging</source>
<year>2010</year>; <volume>29</volume>: <fpage>1626</fpage>&#x02013;<lpage>1635</lpage>.<pub-id pub-id-type="pmid">20304721</pub-id>
</mixed-citation></ref><ref id="R44"><label>44.</label><mixed-citation publication-type="journal"><name><surname>Henf</surname><given-names>J</given-names></name>, <name><surname>Grothe</surname><given-names>MJ</given-names></name>, <name><surname>Brueggen</surname><given-names>K</given-names></name>, <etal/>
<article-title>Mean diffusivity in cortical gray matter in Alzheimer&#x02019;s disease: The importance of partial volume correction</article-title>. <source>Neuroimage Clin</source>
<year>2018</year>; <volume>17</volume>: <fpage>579</fpage>&#x02013;<lpage>586</lpage>. 20171004. DOI: <pub-id pub-id-type="doi">10.1016/j.nicl.2017.10.005</pub-id>.<pub-id pub-id-type="pmid">29201644</pub-id>
</mixed-citation></ref><ref id="R45"><label>45.</label><mixed-citation publication-type="journal"><name><surname>Weston</surname><given-names>PS</given-names></name>, <name><surname>Poole</surname><given-names>T</given-names></name>, <name><surname>Nicholas</surname><given-names>JM</given-names></name>, <etal/>
<article-title>Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer&#x02019;s disease</article-title>. <source>Alzheimer&#x02019;s Research &#x00026; Therapy</source>
<year>2020</year>; <volume>12</volume>: <fpage>1</fpage>&#x02013;<lpage>10</lpage>.</mixed-citation></ref><ref id="R46"><label>46.</label><mixed-citation publication-type="journal"><name><surname>Klunk</surname><given-names>WE</given-names></name>, <name><surname>Koeppe</surname><given-names>RA</given-names></name>, <name><surname>Price</surname><given-names>JC</given-names></name>, <etal/>
<article-title>The Centiloid Project: standardizing quantitative amyloid plaque estimation by PET</article-title>. <source>Alzheimers Dement</source>
<year>2015</year>; <volume>11</volume>: <fpage>1</fpage>&#x02013;<lpage>15</lpage>.e11&#x02013;14. 20141028. DOI: <pub-id pub-id-type="doi">10.1016/j.jalz.2014.07.003</pub-id>.<pub-id pub-id-type="pmid">25443857</pub-id>
</mixed-citation></ref><ref id="R47"><label>47.</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>CC</given-names></name>, <name><surname>Dor&#x000e9;</surname><given-names>V</given-names></name>, <name><surname>Jones</surname><given-names>G</given-names></name>, <etal/>
<article-title>18 F-Florbetaben PET beta-amyloid binding expressed in Centiloids</article-title>. <source>European journal of nuclear medicine and molecular imaging</source>
<year>2017</year>; <volume>44</volume>: <fpage>2053</fpage>&#x02013;<lpage>2059</lpage>.<pub-id pub-id-type="pmid">28643043</pub-id>
</mixed-citation></ref><ref id="R48"><label>48.</label><mixed-citation publication-type="journal"><name><surname>Chen</surname><given-names>APF</given-names></name>, <name><surname>Clouston</surname><given-names>SAP</given-names></name>, <name><surname>Kritikos</surname><given-names>M</given-names></name>, <etal/>
<article-title>A deep learning approach for monitoring parietal-dominant Alzheimer&#x02019;s disease in World Trade Center responders at midlife</article-title>. <source>Brain Commun</source>
<year>2021</year>; <volume>3</volume>: <fpage>fcab145</fpage>. 20210702. DOI: <pub-id pub-id-type="doi">10.1093/braincomms/fcab145</pub-id>.<pub-id pub-id-type="pmid">34396105</pub-id>
</mixed-citation></ref><ref id="R49"><label>49.</label><mixed-citation publication-type="journal"><name><surname>Deri</surname><given-names>Y</given-names></name>, <name><surname>Clouston</surname><given-names>SAP</given-names></name>, <name><surname>DeLorenzo</surname><given-names>C</given-names></name>, <etal/>
<article-title>Selective hippocampal subfield volume reductions in World Trade Center responders with cognitive impairment</article-title>. <source>Alzheimers Dement (Amst)</source>
<year>2021</year>; <volume>13</volume>: <fpage>e12165</fpage>. 20210331. DOI: <pub-id pub-id-type="doi">10.1002/dad2.12165</pub-id>.<pub-id pub-id-type="pmid">33816755</pub-id>
</mixed-citation></ref><ref id="R50"><label>50.</label><mixed-citation publication-type="journal"><name><surname>Maruff</surname><given-names>P</given-names></name>, <name><surname>Thomas</surname><given-names>E</given-names></name>, <name><surname>Cysique</surname><given-names>L</given-names></name>, <etal/>
<article-title>Validity of the CogState brief battery: relationship to standardized tests and sensitivity to cognitive impairment in mild traumatic brain injury, schizophrenia, and AIDS dementia complex</article-title>. <source>Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists</source>
<year>2009</year>; <volume>24</volume>: <fpage>165</fpage>&#x02013;<lpage>178</lpage>. 20090325. DOI: <pub-id pub-id-type="doi">10.1093/arclin/acp010</pub-id>.<pub-id pub-id-type="pmid">19395350</pub-id>
</mixed-citation></ref><ref id="R51"><label>51.</label><mixed-citation publication-type="journal"><name><surname>Nasreddine</surname><given-names>ZS</given-names></name>, <name><surname>Phillips</surname><given-names>NA</given-names></name>, <name><surname>Bedirian</surname><given-names>V</given-names></name>, <etal/>
<article-title>The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment</article-title>. <source>J Am Geriatr Soc</source>
<year>2005</year>; <volume>53</volume>: <fpage>695</fpage>&#x02013;<lpage>699</lpage>. 2005/04/09. DOI: <pub-id pub-id-type="doi">10.1111/j.1532-5415.2005.53221.x</pub-id>.<pub-id pub-id-type="pmid">15817019</pub-id>
</mixed-citation></ref><ref id="R52"><label>52.</label><mixed-citation publication-type="journal"><name><surname>Mann</surname><given-names>FD</given-names></name>, <name><surname>Clouston</surname><given-names>SAP</given-names></name>, <name><surname>Cuevas</surname><given-names>A</given-names></name>, <etal/>
<article-title>Genetic Liability, Exposure Severity, and Post-Traumatic Stress Disorder Predict Cognitive Impairment in World Trade Center Responders</article-title>. <source>J Alzheimers Dis</source>
<year>2023</year>; <volume>92</volume>: <fpage>701</fpage>&#x02013;<lpage>712</lpage>. DOI: <pub-id pub-id-type="doi">10.3233/JAD-220892</pub-id>.<pub-id pub-id-type="pmid">36776056</pub-id>
</mixed-citation></ref><ref id="R53"><label>53.</label><mixed-citation publication-type="book"><name><surname>Robins</surname><given-names>L</given-names></name> and <name><surname>Smith</surname><given-names>E</given-names></name>. <source>The diagnostic interview schedule/disaster supplement</source>. <publisher-loc>St Louis, MO</publisher-loc>: <publisher-name>Washington University School of Medicine</publisher-name>
<year>1983</year>.</mixed-citation></ref><ref id="R54"><label>54.</label><mixed-citation publication-type="journal"><name><surname>Benjamini</surname><given-names>Y</given-names></name> and <name><surname>Hochberg</surname><given-names>Y</given-names></name>. <article-title>Controlling the False Discovery Rate - a Practical and Powerful Approach to Multiple Testing</article-title>. <source>J Roy Stat Soc B Met</source>
<year>1995</year>; <volume>57</volume>: <fpage>289</fpage>&#x02013;<lpage>300</lpage>.</mixed-citation></ref><ref id="R55"><label>55.</label><mixed-citation publication-type="journal"><name><surname>Leuzy</surname><given-names>A</given-names></name>, <name><surname>Chiotis</surname><given-names>K</given-names></name>, <name><surname>Hasselbalch</surname><given-names>SG</given-names></name>, <etal/>
<article-title>Pittsburgh compound B imaging and cerebrospinal fluid amyloid-&#x003b2; in a multicentre European memory clinic study</article-title>. <source>Brain</source>
<year>2016</year>; <volume>139</volume>: <fpage>2540</fpage>&#x02013;<lpage>2553</lpage>.<pub-id pub-id-type="pmid">27401520</pub-id>
</mixed-citation></ref><ref id="R56"><label>56.</label><mixed-citation publication-type="journal"><name><surname>Rowe</surname><given-names>CC</given-names></name>, <name><surname>Jones</surname><given-names>G</given-names></name>, <name><surname>Dor&#x000e9;</surname><given-names>V</given-names></name>, <etal/>
<article-title>Standardized expression of 18F-NAV4694 and 11C-PiB &#x003b2;-amyloid PET results with the Centiloid scale</article-title>. <source>J Nucl Med</source>
<year>2016</year>; <volume>57</volume>: <fpage>1233</fpage>&#x02013;<lpage>1237</lpage>.<pub-id pub-id-type="pmid">26912446</pub-id>
</mixed-citation></ref><ref id="R57"><label>57.</label><mixed-citation publication-type="journal"><name><surname>Kim</surname><given-names>SH</given-names></name>, <name><surname>Knight</surname><given-names>EM</given-names></name>, <name><surname>Saunders</surname><given-names>EL</given-names></name>, <etal/>
<article-title>Rapid doubling of Alzheimer&#x02019;s amyloid-&#x003b2;40 and 42 levels in brains of mice exposed to a nickel nanoparticle model of air pollution</article-title>. <source>F1000Research</source>
<year>2012</year>; <volume>1</volume>: <fpage>70</fpage>. 2012/01/01. DOI: <pub-id pub-id-type="doi">10.12688/f1000research.1-70.v1</pub-id>.<pub-id pub-id-type="pmid">24358824</pub-id>
</mixed-citation></ref><ref id="R58"><label>58.</label><mixed-citation publication-type="journal"><name><surname>Simons</surname><given-names>JS</given-names></name> and <name><surname>Spiers</surname><given-names>HJ</given-names></name>. <article-title>Prefrontal and medial temporal lobe interactions in long-term memory</article-title>. <source>Nat Rev Neurosci</source>
<year>2003</year>; <volume>4</volume>: <fpage>637</fpage>&#x02013;<lpage>648</lpage>. 2003/08/02. DOI: <pub-id pub-id-type="doi">10.1038/nrn1178</pub-id>.<pub-id pub-id-type="pmid">12894239</pub-id>
</mixed-citation></ref><ref id="R59"><label>59.</label><mixed-citation publication-type="journal"><name><surname>Morris</surname><given-names>RG</given-names></name>, <name><surname>Garrud</surname><given-names>P</given-names></name>, <name><surname>Rawlins</surname><given-names>JN</given-names></name>, <etal/>
<article-title>Place navigation impaired in rats with hippocampal lesions</article-title>. <source>Nature</source>
<year>1982</year>; <volume>297</volume>: <fpage>681</fpage>&#x02013;<lpage>683</lpage>. 1982/06/24. DOI: <pub-id pub-id-type="doi">10.1038/297681a0</pub-id>.<pub-id pub-id-type="pmid">7088155</pub-id>
</mixed-citation></ref><ref id="R60"><label>60.</label><mixed-citation publication-type="journal"><name><surname>Sarnyai</surname><given-names>Z</given-names></name>, <name><surname>Sibille</surname><given-names>EL</given-names></name>, <name><surname>Pavlides</surname><given-names>C</given-names></name>, <etal/>
<article-title>Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors</article-title>. <source>Proc Natl Acad Sci U S A</source>
<year>2000</year>; <volume>97</volume>: <fpage>14731</fpage>&#x02013;<lpage>14736</lpage>. 2000/12/20. DOI: <pub-id pub-id-type="doi">10.1073/pnas.97.26.14731</pub-id>.<pub-id pub-id-type="pmid">11121072</pub-id>
</mixed-citation></ref><ref id="R61"><label>61.</label><mixed-citation publication-type="journal"><name><surname>Buffalo</surname><given-names>EA</given-names></name>, <name><surname>Reber</surname><given-names>PJ</given-names></name> and <name><surname>Squire</surname><given-names>LR</given-names></name>. <article-title>The human perirhinal cortex and recognition memory</article-title>. <source>Hippocampus</source>
<year>1998</year>; <volume>8</volume>: <fpage>330</fpage>&#x02013;<lpage>339</lpage>. 1998/09/23. DOI: <pub-id pub-id-type="doi">10.1002/(SICI)1098-1063(1998)8:4&#x0003c;330::AID-HIPO3&#x0003e;3.0.CO;2-L</pub-id>.<pub-id pub-id-type="pmid">9744420</pub-id>
</mixed-citation></ref><ref id="R62"><label>62.</label><mixed-citation publication-type="journal"><name><surname>Holdstock</surname><given-names>JS</given-names></name>, <name><surname>Gutnikov</surname><given-names>SA</given-names></name>, <name><surname>Gaffan</surname><given-names>D</given-names></name>, <etal/>
<article-title>Perceptual and mnemonic matching-to-sample in humans: contributions of the hippocampus, perirhinal and other medial temporal lobe cortices</article-title>. <source>Cortex</source>
<year>2000</year>; <volume>36</volume>: <fpage>301</fpage>&#x02013;<lpage>322</lpage>. 2000/08/02. DOI: <pub-id pub-id-type="doi">10.1016/s0010-9452(08)70843-8</pub-id>.<pub-id pub-id-type="pmid">10921661</pub-id>
</mixed-citation></ref></ref-list></back><floats-group><fig position="float" id="F1"><label>Figure 1.</label><caption><title>Hypothesized linkages between neurotoxic exposures at the World Trade Center (WTC).</title><p id="P49">We theorize that due to the possible presence of chronic (&#x0003e;20 years) cerebral WTC dust infiltrates that have actively and passively flowed from the initial sites of insult, i.e., the olfactory nerve area, to anatomically connected neighboring neural networks such as, but not limited to, the inferior frontal lobe. Clouston, S. 2023. <ext-link xlink:href="http://BioRender.com/w86b800" ext-link-type="uri">BioRender.com/w86b800</ext-link>.</p></caption><graphic xlink:href="nihms-2086140-f0001" position="float"/></fig><fig position="float" id="F2"><label>Figure 2.</label><caption><title>Surface projection of cortical amyloid burden in cognitively impaired World Trade Center responders as compared to cognitively unimpaired responders.</title><p id="P50">Images only report increased FBB-SUVR where statistically significant results are evident (p&#x0003c;0.05). Results are statistically significant at the cluster level after adjusting for the false discovery rate (FDR = 0.05) in three clusters (cluster-centroids (P&#x0003c;0.001) located at: 15, &#x02212;27, 70 [right precentral, P]; 16, 48, 1 [right superior frontal], and &#x02212;8, 55, &#x02212;7 [left medial orbitofrontal]).</p></caption><graphic xlink:href="nihms-2086140-f0002" position="float"/></fig><fig position="float" id="F3"><label>Figure 3.</label><caption><title>Scatter plots showing best-fitting lines and 95% confidence intervals showing bivariate associations.</title><p id="P51">(a) associations between (A) World Trade Center (WTC) site exposure duration (months) and regional [<sup>18</sup>F]florbetaben (FBB) uptake in the olfactory cortex, (B) [<sup>18</sup>F]florbetaben (FBB) uptake in the olfactory cortex and in olfactory-adjacent cortices, and (C) [<sup>18</sup>F]florbetaben (FBB) uptake in the olfactory olfactory-adjacent cortices and in previously identified WTC-affected ROIs (Panel C).</p></caption><graphic xlink:href="nihms-2086140-f0003" position="float"/></fig><table-wrap position="float" id="T1"><label>Table 1.</label><caption><p id="P52">Clinical characteristics of the World Trade Center responder sample who completed the simultaneous positron emission tomography and magnetic resonance imaging protocol.</p></caption><table frame="below" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="left" valign="bottom" rowspan="1" colspan="1">Characteristic</th><th align="center" valign="bottom" rowspan="1" colspan="1">Sample (N=35)</th><th align="center" valign="bottom" rowspan="1" colspan="1">WTC Exposure Duration &#x0003c; 6 months (n=18)</th><th align="center" valign="bottom" rowspan="1" colspan="1">WTC exposure duration &#x02265; 6 months (n=17)</th><th align="center" valign="bottom" rowspan="1" colspan="1">P-Value</th></tr><tr><th colspan="5" align="center" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">Age, years</td><td align="center" valign="middle" rowspan="1" colspan="1">55.8 (5.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">55.61 (6.01)</td><td align="center" valign="middle" rowspan="1" colspan="1">56 (4.46)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.79</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Body Mass Index, kg/m<sup>2</sup></td><td align="center" valign="middle" rowspan="1" colspan="1">29.22 (4.23)</td><td align="center" valign="middle" rowspan="1" colspan="1">28.9 (4.24)</td><td align="center" valign="middle" rowspan="1" colspan="1">29.57 (4.32)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.57</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Female, vs. Male</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (25.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (22.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (29.4%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.63</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Non-White Race/Ethnicity, vs. White</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (25.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (27.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (23.5%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.78</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Education</td><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="left" valign="bottom" rowspan="1" colspan="1"/><td align="center" valign="bottom" rowspan="1" colspan="1"/></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;High School or less</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (28.6%)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (44.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">2 (11.8%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">&#x02013;</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;Some College</td><td align="center" valign="middle" rowspan="1" colspan="1">13 (37.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (1800%)</td><td align="center" valign="middle" rowspan="1" colspan="1">17 (1700%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.32</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">&#x02003;College Diploma</td><td align="center" valign="middle" rowspan="1" colspan="1">12 (34.3%)</td><td align="center" valign="middle" rowspan="1" colspan="1">36 (1800%)</td><td align="center" valign="middle" rowspan="1" colspan="1">34 (1700%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.10</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Untrained Responder, vs. Trained</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (22.9%)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (22.2%)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (23.5%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.37</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Early Arrival 9/11&#x02013;9/12</td><td align="center" valign="middle" rowspan="1" colspan="1">28 (80%)</td><td align="center" valign="middle" rowspan="1" colspan="1">14 (77.8%)</td><td align="center" valign="middle" rowspan="1" colspan="1">14 (82.4%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.74</td></tr><tr><td align="left" valign="bottom" rowspan="1" colspan="1">Post-Traumatic Stress Disorder, vs. None</td><td align="center" valign="middle" rowspan="1" colspan="1">18 (51.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">8 (44.4%)</td><td align="center" valign="middle" rowspan="1" colspan="1">10 (58.8%)</td><td align="center" valign="bottom" rowspan="1" colspan="1">0.86</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">Apolipoprotein-&#x003b5;4<sup>&#x02020;</sup> allele, vs. none</td><td align="center" valign="middle" rowspan="1" colspan="1">9 (32.1%)</td><td align="center" valign="middle" rowspan="1" colspan="1">4 (25%)</td><td align="center" valign="middle" rowspan="1" colspan="1">5 (41.7%)</td><td align="center" valign="middle" rowspan="1" colspan="1">0.36</td></tr></tbody></table><table-wrap-foot><fn id="TFN1"><p id="P53"><bold>Note</bold>: Means (standard deviation) or Percentages (%) reported. In dichotomous variables, frequencies and percentages for only one group was shown and the reference category was listed using the versus label. P-values were estimated using Welch&#x02019;s T-Test or Chi-Squared tests. SD: standard deviation, cs: centiseconds; kg/m<sup>2</sup>: kilograms per meter squared. &#x02020;Apolipoprotein-&#x003b5;4 status was only available for 28/35 participants.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T2"><label>Table 2.</label><caption><p id="P54">Associations between unilateral region-specific tracer uptake and two markers of neurodegeneration.</p></caption><table frame="below" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th rowspan="3" align="left" valign="middle" colspan="1">Lobe</th><th rowspan="3" align="left" valign="middle" colspan="1">Region</th><th colspan="2" align="center" valign="bottom" rowspan="1">Cortical Mean Diffusivity</th><th colspan="2" align="center" valign="bottom" rowspan="1">Cortical Thickness, mm</th></tr><tr><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th><th colspan="2" align="center" valign="top" rowspan="1">
<hr/>
</th></tr><tr><th align="center" valign="bottom" rowspan="1" colspan="1">Left</th><th align="center" valign="bottom" rowspan="1" colspan="1">Right</th><th align="center" valign="bottom" rowspan="1" colspan="1">Left</th><th align="center" valign="bottom" rowspan="1" colspan="1">Right</th></tr><tr><th colspan="6" align="center" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td rowspan="10" align="center" valign="middle" colspan="1">Frontal</td><td align="left" valign="top" rowspan="1" colspan="1">Superior Frontal</td><td style="background-color:#8F9DBA;" align="right" valign="top" rowspan="1" colspan="1">0.44</td><td style="background-color:#BAC3D6;" align="right" valign="top" rowspan="1" colspan="1">0.26</td><td style="background-color:#EBB4B6;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.28</td><td style="background-color:#EAB1B3;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.30</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rostral Middle Frontal</td><td style="background-color:#E5E8F1" align="right" valign="top" rowspan="1" colspan="1">0.09</td><td style="background-color:#7788AB" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.53</italic>
</bold>
</td><td style="background-color:#E9ACAE" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.32</td><td style="background-color:#E6A0A2" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Caudal Middle Frontal</td><td style="background-color:#8695B5" align="right" valign="top" rowspan="1" colspan="1">0.47</td><td style="background-color:#ABB5CC" align="right" valign="top" rowspan="1" colspan="1">0.32</td><td style="background-color:#F4DADD" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.13</td><td style="background-color:#E6A2A4" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.36</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pars Opercularis</td><td style="background-color:#7283A8" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.55</italic>
</bold>
</td><td style="background-color:#BCC4D7" align="right" valign="top" rowspan="1" colspan="1">0.26</td><td style="background-color:#EAB4B6" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.28</td><td style="background-color:#E18C8D" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.44</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pars Orbitalis</td><td style="background-color:#F9F0F3" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.05</td><td style="background-color:#7183A8" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.55</italic>
</bold>
</td><td style="background-color:#F9F0F3" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.04</td><td style="background-color:#F0CCCE" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.19</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pars Triangularis</td><td style="background-color:#8D9BB9" align="right" valign="top" rowspan="1" colspan="1">0.44</td><td style="background-color:#7C8CAE" align="right" valign="top" rowspan="1" colspan="1">0.51</td><td style="background-color:#E18C8D" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.44</td><td style="background-color:#E18D8F" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.44</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lateral Orbitofrontal</td><td style="background-color:#E9EBF3" align="right" valign="top" rowspan="1" colspan="1">0.08</td><td style="background-color:#4D6491" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.70</italic>
</bold>
</td><td style="background-color:#EFC8CB" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.20</td><td style="background-color:#F6E5E8" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.09</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Medial Orbitofrontal</td><td style="background-color:#F8F8FD" align="right" valign="top" rowspan="1" colspan="1">0.02</td><td style="background-color:#6F81A7" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.56</italic>
</bold>
</td><td style="background-color:#EEC3C6" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.22</td><td style="background-color:#E7A6A8" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.34</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Paracentral</td><td style="background-color:#9AA6C1" align="right" valign="top" rowspan="1" colspan="1">0.39</td><td style="background-color:#7E8EB0" align="right" valign="top" rowspan="1" colspan="1">0.50</td><td style="background-color:#F5E1E4" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.10</td><td style="background-color:#F3D8DB" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Precentral</td><td style="background-color:#697CA3" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.58</italic>
</bold>
</td><td style="background-color:#64779F" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.61</italic>
</bold>
</td><td style="background-color:#F1D1D3" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.17</td><td style="background-color:#F3D7DA" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.14</td></tr><tr><td colspan="6" align="center" valign="top" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="6" align="center" valign="middle" colspan="1">Parietal</td><td align="left" valign="top" rowspan="1" colspan="1">Superior Parietal</td><td style="background-color:#5B709A;" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.64</italic>
</bold>
</td><td style="background-color:#687BA2;" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.59</italic>
</bold>
</td><td style="background-color:#EFC6C8;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.21</td><td style="background-color:#EDBDBF;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.25</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Inferior Parietal</td><td style="background-color:#6D7FA5" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.57</italic>
</bold>
</td><td style="background-color:#586D98" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.65</italic>
</bold>
</td><td style="background-color:#EEC1C4" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.23</td><td style="background-color:#E8AAAC" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.32</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Supramarginal</td><td style="background-color:#5E729B" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.63</italic>
</bold>
</td><td style="background-color:#536995" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.67</italic>
</bold>
</td><td style="background-color:#E59D9F" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.37</td><td style="background-color:#E39798" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.40</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Postcentral</td><td style="background-color:#A4AFC8" align="right" valign="top" rowspan="1" colspan="1">0.35</td><td style="background-color:#7485A9" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.54</italic>
</bold>
</td><td style="background-color:#F6E4E7" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.09</td><td style="background-color:#F2D4D7" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.16</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Precuneus</td><td style="background-color:#7A8BAD" align="right" valign="top" rowspan="1" colspan="1">0.52</td><td style="background-color:#60749D" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.62</italic>
</bold>
</td><td style="background-color:#E7A7A9" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.34</td><td style="background-color:#E6A2A4" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.35</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Insula</td><td style="background-color:#536894" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.67</italic>
</bold>
</td><td style="background-color:#4D6391" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.70</italic>
</bold>
</td><td style="background-color:#E59D9F" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.37</td><td style="background-color:#F9F2F5" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.04</td></tr><tr><td colspan="6" align="center" valign="top" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="5" align="center" valign="middle" colspan="1">Temporal</td><td align="left" valign="top" rowspan="1" colspan="1">Superior Temporal</td><td style="background-color:#DEE2EC;" align="right" valign="top" rowspan="1" colspan="1">0.12</td><td style="background-color:#8998B7;" align="right" valign="top" rowspan="1" colspan="1">0.46</td><td style="background-color:#EAB2B4;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.29</td><td style="background-color:#F3D7D9;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.15</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Middle Temporal</td><td style="background-color:#C1C9DA" align="right" valign="top" rowspan="1" colspan="1">0.24</td><td style="background-color:#C5CCDC" align="right" valign="top" rowspan="1" colspan="1">0.22</td><td style="background-color:#E59D9F" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.38</td><td style="background-color:#EBB4B6" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.28</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Inferior Temporal</td><td style="background-color:#D1D6E4" align="right" valign="top" rowspan="1" colspan="1">0.17</td><td style="background-color:#6B7EA4" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.58</italic>
</bold>
</td><td style="background-color:#F5E2E5" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.10</td><td style="background-color:#ECBABD" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.26</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Fusiform</td><td style="background-color:#6B7DA4" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.58</italic>
</bold>
</td><td style="background-color:#E4E7F0" align="right" valign="top" rowspan="1" colspan="1">0.10</td><td style="background-color:#EAB1B3" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.30</td><td style="background-color:#EDC0C3" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.23</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Transverse Temporal</td><td style="background-color:#49608E" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.71</italic>
</bold>
</td><td style="background-color:#8998B7" align="right" valign="top" rowspan="1" colspan="1">0.46</td><td style="background-color:#F0CCCE" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.19</td><td style="background-color:#F6E4E7" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.09</td></tr><tr><td colspan="6" align="center" valign="top" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="4" align="center" valign="middle" colspan="1">Occipital</td><td align="left" valign="top" rowspan="1" colspan="1">Lateral Occipital</td><td style="background-color:#7284A8;" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.55</italic>
</bold>
</td><td style="background-color:#5D719B;" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.63</italic>
</bold>
</td><td style="background-color:#F1CFD2;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.17</td><td style="background-color:#ECBABD;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.26</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lingual</td><td style="background-color:#6C7EA4" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.57</italic>
</bold>
</td><td style="background-color:#EEF0F6" align="right" valign="top" rowspan="1" colspan="1">0.06</td><td style="background-color:#E8ABAD" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.32</td><td style="background-color:#F3D9DB" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.14</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Cuneus</td><td style="background-color:#6679A0" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.60</italic>
</bold>
</td><td style="background-color:#7788AB" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.53</italic>
</bold>
</td><td style="background-color:#E6A0A2" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.36</td><td style="background-color:#E7A5A7" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.34</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Pericalcarine</td><td style="background-color:#7E8EB0" align="right" valign="top" rowspan="1" colspan="1">0.50</td><td style="background-color:#B5BED2" align="right" valign="top" rowspan="1" colspan="1">0.28</td><td style="background-color:#EFC5C8" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.21</td><td style="background-color:#F1D0D3" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.17</td></tr><tr><td colspan="6" align="center" valign="top" rowspan="1">
<hr/>
</td></tr><tr><td rowspan="5" align="center" valign="middle" colspan="1">Limbic</td><td align="left" valign="top" rowspan="1" colspan="1">Para hippocampal Gyrus</td><td style="background-color:#97A4C0;" align="right" valign="top" rowspan="1" colspan="1">0.40</td><td style="background-color:#8090B1;" align="right" valign="top" rowspan="1" colspan="1">0.50</td><td style="background-color:#EBEDF4;" align="right" valign="top" rowspan="1" colspan="1">0.07</td><td style="background-color:#F6E3E6;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.10</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Rostral Anterior Cingulate</td><td style="background-color:#CCD2E1" align="right" valign="top" rowspan="1" colspan="1">0.19</td><td style="background-color:#7788AB" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.53</italic>
</bold>
</td><td style="background-color:#F1D0D3" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.17</td><td style="background-color:#E8A8AA" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.33</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Anterior Cingulate</td><td style="background-color:#A2AEC6" align="right" valign="top" rowspan="1" colspan="1">0.36</td><td style="background-color:#8897B6" align="right" valign="top" rowspan="1" colspan="1">0.46</td><td style="background-color:#F2D3D6" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.16</td><td style="background-color:#F7F7FC" align="right" valign="top" rowspan="1" colspan="1">0.02</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Isthmus Cingulate</td><td style="background-color:#63769F" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">0.61</italic>
</bold>
</td><td style="background-color:#BBC3D6" align="right" valign="top" rowspan="1" colspan="1">0.26</td><td style="background-color:#E49A9C" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.39</td><td style="background-color:#DC7778" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">&#x02212;0.53</italic>
</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Posterior Cingulate</td><td style="background-color:#C8CFDE" align="right" valign="top" rowspan="1" colspan="1">0.21</td><td style="background-color:#909EBB" align="right" valign="top" rowspan="1" colspan="1">0.43</td><td style="background-color:#EAB3B5" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.29</td><td style="background-color:#EBB6B8" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.28</td></tr></tbody></table><table-wrap-foot><fn id="TFN2"><p id="P55"><bold>Note</bold>: Heat map (blue = positive; red = negative) displaying Spearman&#x02019;s associations between cortical region-specific FBB uptake with two measures of neurodegeneration &#x02013; mean diffusivity and cortical thickness (mm). All nominally significant correlations are shown in black typeface and all correlations that survived multiple comparisons correction (FDR &#x0003c; .05) are shown in italicized black typeface.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="T3"><label>Table 3.</label><caption><p id="P56">Heat table showing Spearman correlations between measures of whole-brain and regional FBB uptake with measures of cognition.</p></caption><table frame="below" rules="none"><colgroup span="1"><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/><col align="left" valign="middle" span="1"/></colgroup><thead><tr><th align="center" valign="top" rowspan="1" colspan="1"/><th align="center" valign="top" rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">Episodic Memory</th><th align="center" valign="middle" rowspan="1" colspan="1">Visual Memory</th><th align="center" valign="middle" rowspan="1" colspan="1">Throughput</th><th align="center" valign="middle" rowspan="1" colspan="1">Intraindividual Variability</th><th align="center" valign="middle" rowspan="1" colspan="1">Response Speed</th><th align="center" valign="middle" rowspan="1" colspan="1">Processing Speed</th><th align="center" valign="middle" rowspan="1" colspan="1">Visuospatial Functioning</th><th align="center" valign="middle" rowspan="1" colspan="1">Visuospatial Memory</th></tr><tr><th colspan="10" align="center" valign="top" rowspan="1">
<hr/>
</th></tr></thead><tbody><tr><td rowspan="4" align="center" valign="middle" colspan="1">
<bold>Global</bold>
</td><td align="center" valign="top" rowspan="1" colspan="1">
<bold>Olfactory FBB</bold>
</td><td style="background-color:#F4DEE1;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.12</td><td style="background-color:#F5DEE1;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.12</td><td style="background-color:#F0CDCF;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.19</td><td style="background-color:#E7E9F2;" align="right" valign="top" rowspan="1" colspan="1">0.09</td><td style="background-color:#F3D7DA;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.14</td><td style="background-color:#F8EBEE;" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.07</td><td style="background-color:#EBEEF5;" align="right" valign="top" rowspan="1" colspan="1">0.07</td><td style="background-color:#D9DDE9;" align="right" valign="top" rowspan="1" colspan="1">0.14</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">
<bold>Olfactory-Adjacent</bold>
</td><td style="background-color:#EFC9CB" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.20</td><td style="background-color:#F0CCCE" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.19</td><td style="background-color:#EAB4B6" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.29</td><td style="background-color:#F8EEF0" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.06</td><td style="background-color:#F4DEE0" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.12</td><td style="background-color:#FBFBFE" align="right" valign="top" rowspan="1" colspan="1">0.00</td><td style="background-color:#EFF1F7" align="right" valign="top" rowspan="1" colspan="1">0.05</td><td style="background-color:#E6E9F1" align="right" valign="top" rowspan="1" colspan="1">0.09</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">
<bold>WTC Regional FBB</bold>
</td><td style="background-color:#E18E90" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.43</td><td style="background-color:#E18B8D" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.45</td><td style="background-color:#D86768" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">&#x02212;0.59</italic>
</bold>
</td><td style="background-color:#F4DEE1" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.12</td><td style="background-color:#D04747" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">&#x02212;0.72</italic>
</bold>
</td><td style="background-color:#E69FA1" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.37</td><td style="background-color:#DE8182" align="right" valign="top" rowspan="1" colspan="1">
<bold>
<italic toggle="yes">&#x02212;0.49</italic>
</bold>
</td><td style="background-color:#EBB7B9" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.27</td></tr><tr><td align="center" valign="top" rowspan="1" colspan="1">
<bold>Centiloid</bold>
</td><td style="background-color:#F7F8FC" align="right" valign="top" rowspan="1" colspan="1">0.02</td><td style="background-color:#F5DEE1" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.12</td><td style="background-color:#F4DDDF" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.12</td><td style="background-color:#ECEEF5" align="right" valign="top" rowspan="1" colspan="1">0.06</td><td style="background-color:#F5F6FB" align="right" valign="top" rowspan="1" colspan="1">0.03</td><td style="background-color:#FBF8FB" align="right" valign="top" rowspan="1" colspan="1">&#x02212;0.02</td><td style="background-color:#FBFBFE" align="right" valign="top" rowspan="1" colspan="1">0.00</td><td style="background-color:#DBDFEA" align="right" valign="top" rowspan="1" colspan="1">0.13</td></tr></tbody></table><table-wrap-foot><fn id="TFN3"><p id="P57"><bold>Note</bold>: WTC SUVR indicates SUVRs averaged across regions of interest in WTC responder studies. All nominally significant correlations are shown in black typeface, and all correlations that survived multiple comparisons correction (FDR &#x0003c; .05) are shown in <italic toggle="yes"><bold>bold italics</bold></italic>.</p></fn></table-wrap-foot></table-wrap></floats-group></article>